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CHAPTER I
INTRODUCTION
"In developing countries, as their economies grow, non-communicable diseases
will become more prevalent largely because of the adoption of 'western' lifestyles and
their accompanying factors-smoking, high-fat diets, lack of exercise."
(The World Health Report 1998) (1)
OvelWeight and obesity are associated with a variety of health maladies, including
cardiovascular diseases such as hypertension, stroke, coronary artery disease, type 2
diabetes, and cancers-all factors affecting quality of life for those affected by them.
Obesity, especially central or android obesity, has been identified as the foremost
contributing factor to insulin resistance (2;3).
Insulin resistance is the impaired ability of insulin to stimulate glucose uptake by
cells and to suppress glucose production by the liver. Hyperinsulinemia, an abnormally
high level of insulin in the blood, is one characteristic of impaired insulin sensitivity, and
may be accompanied by elevated levels of glucose in circulation. The net effect is less
glucose clearance for a given amount of insulin in the blood. There is also an increase in
the utilization of fatty acids, especially by muscle. Type 2 diabetes, which often develops
within ten years of the onset of insulin resistance, is a result of untreated insulin
resistance, followed by a decrease in insulin production by the pancreatic B-cells (4-6).
In industrialized nations such as the United States, highly refined, high-fat diets
are common. In the US, total caloric intake has increased since the 1970's, due in part to
higher consumption of added fats such as salad dressings and cooking oils (7). At 33% of
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calories, this is still above fat intake recommendations outl~ned in the Dietary Guidelines
fOf. Americans (8), which are associated with lower rates of lifestyle-related chronic
illnesses (9). With this increase in fat and calorie intake over time, there has been an
increase in the incidence and prevalence of overweight and type 2 diabetes mellitus in
persons who are overweight and obese (10). This same increase in incidence· is seen in
Asian peoples at body mass indexes considered acceptable for northern Europeans and
Americans (4).
Subjects with type 2 diabetes who were able to lose excess weight had increased
insulin sensitivity, decreased hepatic glucose output, and increased insuiin sensitivity,
continning a relationship between adiposity and insulin resistance (3;11;12).
Diets high in fat are known to increase body weight and fat mass, induce
alterations in carbohydrate and lipid metabolism, lead to insulin resistance, and increase
production and release of the hormone leptin in humans, rodents, and other animals (13-
17).
Leptin, which is produced and released by adipocytes, exhibits adiumal pattern of
presence in the blood (18-20), is significantly correlated to insulin resistance (21 ;22), and
is released in response to increased insulin lev:els in the blood (23;24). Leptin inhibits
insulin secretion (25-28), provides an increased sensation of satiety in nonnal weight
individuals (20), and decreases food intake in labora ory animals (29-32). Since it is
produced by adipose tissue, systemic leptin concentrations are positively correlated with
fat inass(3;33;34).Obese individuals produce twice the amount ofleptincompar:ed to
slender individuals, and ~here is evidence indicating this is due to increased production- of
leptin by subcutaneous adipocytes compared to visceral fat cells (35;36). There is clear
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indication that gender honnones are related to leptin levels in the blood as early as
infancy (37) and in relation to sexual maturation (33;38). Fat cell size and maturity are
also related to leptin levels in the blood (35;36).
Growth honnone (GH) administration has been shown to impair insulin
sensitivity under various conditions (39-41). Produced by the anterior pituitary gland, GH
stimulates the growth of lean body mass and reduction ofbody fat mass (42;43). It plays a
role in the development of insulin resistance at puberty to promote growth and is
associated with insulin resistance and diabetes in individuals with excess GH secretio'n.
Conversely, GH deficient individuals (43) and animals (44) have lower lean body mass,
are obese, and exhibit increased circulating insulin levels and insulin resistance (45;46).
GH declines with age (47;48) and energy restriction (47;49), and increases with
overfeeding and growth (49;50).
Some research has been perfonned examining the various relationships between
high-fat diets, obesity, glucose tolerance, growth honnone, and leptin. While animal
studies examining the effects of intravenous glucose challenges on leptin secretion have
been perfonned following dietary manipulation, we know of no studies utilizing oral
glucose challenges, with the exception being our previous unpublished research, which
utilized weanling rats though the development of sexual maturity. Most of the previous
research has involved mature male rats (15;16;51-57). Results of this research will ,offer
insight into the relationship between high-fat diets and the roles ofleptin and growth
hormon,e in th'e development of insulin resistance associated with increased fat mass and
overweight in female rat models.
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Therefore, the following research hypotheses were developed:
1. Rats fed high-fat diets will have greater total body mass and body fat content
compared to rats isocalorically fed low-fat diets.
2. Rats fed high-fat diets will produce significantly higher leptin responses to oral
glucose tolerance challenges compared to rats isocalorically fed low-fat diets during
growth.
3. Rats fed high-fat diets will develop insulin resistance, evidenced by amplified insulin
responses to oral glucose tolerance tests, compared to isocalorically low-fat fed rats.
4. Growth honnone concentrations of rats fed high-fat diets will not be different from
growth honnone concentrations of rats isocalorically fed low-fat diets.
Based on the hypotheses, the following research objectives were developed:
1. To detennine the effects of dietary fat content on growth (weight gain) and adiposity
(% body fat) in rats isocalorically fed diets that have high or low fat content.
2. To determine the effects of dietary fat content on glucose, insulin, leptin and growth
honnone responses to oral glucose tolerance tests over time.
Limitations
This study was designed to evaluate the effects of high-fat feeding during rapid
growth in female rats. Due to limited resources, we were not able to examine rats younger
than 56 days of age. The animals are too small before this age to withstand the procedures
involved in this study. This study is also limited to female SD rats. Results of this
research cannot be directly extrapolated to humans. Therefore, human research is also
indicated to examine if similar physiological responses occur.
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Thesis Format
This thesis contains five chapters: the introduction, literature review,
methodology, results in the fonn of a journal article, and a summary, conclusions and
recommendation section. The bibliography and journal article are written in the format
required by Diabetes, the journal of the American Diabetes Association.
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CHAPTER II
REVIEW OF LITERATURE
Obesity and Type 2 Diabetes Mellitus
Overweight and obesity are growing problems in industrialized nations such as the
United States. National health initiatives such as Healthy People 2010 and the Dietary
Guidelines for Americans recommend balancing physical activity with a diet of
appropriate calories and less than 30% of energy from fat to maintain body mass index
(BMD associated with low rates of morbidity and mortality (9).
Obesity is highly associated with insulin resistance and the development of type 2
diabetes mellitus (DM). BMI positively correlates with the degree of insulin resistance in
obese probands, as does waist circumference (2). Weight loss attenuates hyperglycemia,
hyperinsulinemia, hypertension, and blood lipid parameters, indicating that excess weight
is a contributing factor in the development of such metabolic aberrations. A 28-day diet
and exercise intervention to reduce weight in obese men (BMI 32.1 ± 3.9 at baseline, 30.7
± 3.9 at conclusion, p < 0.001) with untreated type 2 DM resulted in improved blood
glucose (10.2 ± 3.3 to 6.8 ±2.2 mmol/ L). Serum insulin levels were also significantly
reduced after the intervention, though values were within reference range at baseline (3).
Reference fasting serum insulin values are 1-20 JlU/ mL (6). Subjects' blood lipid profiles
also improved significantly.
Overt DM is a failure to produce adequate insulin to maintain optimal blood
glucose levels. Classic clinical symptoms of overt DM include hyperphagia, polydypsia,
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polyuria, and weight loss. Currently, DM is classified into two categories: type 1 DM, in
which the pancreas does not produce normal levels of insulin, if any at all, and type 2
DM, in which there is a relative deficiency of insulin to maintain Donnal blood glucose
levels. When untreated, type 2 DM can progress to pancreatic fatig'ue and reduced insulin
production (10). Roughly 10 to 20% ofDM cases are type 1 which is the result of
autoimmune-mediated destruction of the pancreatic beta cells. The remaining 80 to 90%
of cases are of type 2, which may be caused by "insulin secretory defects, and resistance of
the hepatic and peripheral cells to insulin, resulting in a relative deficiency of insulin to
maintain nonnal blood glucose concentrations (6).
Current criteria for the diagnosis of DM are:
Fasting (8 + hours) serum glucose ~ 126 mg!dL (7.0 mmol/ L), or
Random blood glucose concentration ~ 200 mg!dL (7.8 mmol/ L) with
classical symptoms, or
Fasting blood glucose ~ 126 mg! dL (7.0 mmoll L) results in a provisional
DM diagnosis.
. All of the above findings must be confinned on another day.
Two-hour blood glucose concentration ~ 200 mg!dl (7.8 mmol/ L) following
a 75 goral glucose load.
Based on these criteria, it is estimated that diagnosis occurs an average of six and
a half years after DM has developed (58). Obesity is present in --80% of type 2 DM
patients at the time of diagnosis (10).
In addition to impaired glucose rn-etabolism, patients with poorly controlled DM
have altered lipid metabolism, micro- and macro-vascular changes which frequently lead
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to hypertension, an increased risk ofheart disease, blindne~s due to retinopathy, renal
failure, and amputations. Individuals with type 2 DM are significantly more obese,
dyslipidemic, and hypertensive than age- and gender-matched controls (5). In a study of
Chinese patients with type 2 DM, more than 20% were c1entrally obese, and nearly half
were generally obese. Of the obese patients with type 2 DM, 6% were hypertensive, 230/0
had dyslipidemia, and 27% had increased albuminuria (4). Initiation and continuation of
DM treatment generally results ina rapid and prolonged decrease in total and LDL
cholesterol, ali increase in HDL cholesterol, and a mild reduction ofplasma triglycerides
in type 2 DM patients (59).
In the development of overt type 2 DM, there are two possible conditions of
aberrant glucose tolerance that may be diagnosed prior to absolute DM, which are both
classified as Pre-diabetes (60). Impaired Glucose Tolerance maybe diagnosed if fasting
glucose is ~ 110 but < 126 mg/dl (6.0 to 7.0 mmol/ L), and the two-hour blood glucose
value is ~ 140 but < 200 mg/dl (7.8 to 11.1 mmoV L), following a 75 g oral glucose load.
Impaired Fasting Glucose may be diagnosed if either the fasting or two-hour glucose
concentrations are within the ranges for fasting or two-hour post-load listed for Impaired
Glucose Tolerance, but not both. These conditions are frequ~ntlyasymptomatic, and
aberrations in glucose tolerance may not be diagnosed until overt clinical symptoms
develop (6;10).
The transition from impaired fasting glucose to impaired glucose tolerance and the
development of overt type 2 DM is progressive, as evidenced by the UK Prospective
Diabetes Study. ·Of over five thousand adult patients with type 2 DM studied for the~rst
nine years following diagnosis, the proportion ofpatients receiving various treatments
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(diet, insulin, sulfonylurea, or metfonnin) who were able to achieve glycosylated
hemoglobin < 7.0% and fasting plasma glucose concentrations of < 7.8 mmol/ L
decreased after three, six, and nine years of treatment, regardless of therapy. These resu t8
include both ovelWeight and nonnal weight patients, although the attainment ofblood
glucose control was generally lower in ovelWeight patients than in the entire cohort.
Therapies evaluated included insulin, oral hypoglycemic agents (OHA), diet, or a
combination. of treatments (5).
Effects of high-fat diet on Glucose Tolerance and Insulin Resistance
In human studies, the effects of high-fat diets have been inconsistent and in
conflict with epidemiological data. This may be due to many factors involved in the
response to glucose loading, which are not similarly controlled between studies. Short
tenn feeding ofhigh-fat diets in humans does not seem to cause insulin resistance.
However, in these studies, researchers did not consider the subjects' usual diets as an
influence on their responses to glucose tolerance tests. Gender seemed to have an effect
on insulin secretion in response to a single HF meal (79% of calories from fat) in one
study. Mean serum insulin levels ofwomen were not different postprandially compared to
fasting levels while men's plasma insulin levels were significantly higher one hour after
the meal compared to fasting. In both men and women, insulin levels following the high-
fat meal wer~ significantly lower than after a eucaloric LF meal (1 % of calories). This
reflects a decreased physiologic need for insulin due to decreased carbohydrate entering
the body (61).
Following thee. weeks of diet treatment, fasting a ,d non-fasting glucose and
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insulin levels were not different betw,een HF or LF overfed healthy young men. This
indicates that length of exposure to HF diets is a factor in the development of impaired
glucose tolerance in humans (62). In eight healthy male and female volunteers, no
significant differences in baseline insulin or glucose levels, or in the glucose infusion rate
required to maintain euglycemia were found after thee weeks ofrandomiz·ed high-fat (~
45% calories from predominantly saturated fat) or low-fat (>30% ·of calories from fat)
diet treatment. Time is a factor in the development of insulin resistance (63).
In animal models, evidence of impaired glucose tolerance due to high-fat feeding
is mixed due to varied experimental designs utilizing d· fferent feeding durations, animal
models, population samples, and dietary fat sources and content. A comprehensive table
of rodent studies describing the rodent model, treatment diets, and method of insulin
sensitivity evaluation is found in Appendix A. Research in dogs demonstrated that the
consumption ofdiets containing 80% of calories from fat resulted in elevated fasting
levels ofboth glucose and insulin compared to concentration when dogs were fed low-fat
chow diets (14). Insulin sensitivity was decreased, as demonstrated by a lower rate of
glucose disappearance after the dogs were fed the HF diets for 7 weeks. In this study,
blood was sampled 44 times over a 24-h period in which animals had free access to food
and water. When fed the HF diet, 24-h m'ean glucose concentrations and mean time-
weighted average 24-h insulin concentrations were lower compared to when the dogs
were fed chow. As would be expected, lower carbohydrate and higher fat intakes require
a reduced amount of insulin due to the reduced carbohydrate-stimulated blood glucose
Increases.
Research in rats examining the effects ofHF feeding on glucose and insulin
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concentrations is equivocal. Several researchers have not f?und differences in fasting
insulin and glucose levels between rats fed high and low levels of dietary fat for thee or
more weeks (32;52;56;62). Other researchers have demonstrated that feeding rats HF
diets for the same period of time results in increased fasting glucose concentrations, but
not fasting insulin concentrations (13;16;17). Rats fed very HF diets (90.7%) for ten days
had significantly higher serum glucose and insulin levels compared to chow-fed controls
(146.5 ± 3.1 vs. 126.3 ~ 3.5 mg/dl, and 10.2 ± 1.9 vs. 1.7 ± .3 ng/ml, respectively) (15).
Mice exhibit impaired glucose tolerance and insulin sensitivity in response to
high-fat feeding. After 1.5 years of diet treatment (58% ofkcal from fat), in both
C57BL/6J (from which the ob/ob mouse originated) and NMRI strains of mice, fasting
glucose levels were elevated only in HF C·57BL/6J mice over controls of the same strain.
Plasma concentrations of insulin at necropsy were greater in HF mice compared to chow
fed animals ofboth strains. Intraperitoneal glucose tolerance tests in these mice
demonstrated that HF feeding results in an increased area under the two-hour glucose
curve in HF animals compared to LF animals (64). These same effects were observed
following shorter durations ofHF diet treatment (21).
Similar responses have been observed in rats. After feeding rats treatment diets for
the"e weeks, some researchers have not found differences in acute insulin responses to
low-dose (300 mg/ BWkg or 500 mg/ BW kg) intravenous glucose administration
following a fast. However, HF animals exhibited increased blood glucose levels over LF
animals (51;56). Kraegen, Clark, and colleagues (51) did not find any differences in
insulin and glucose concentrations between HF and LF animals after thee days or thee
weeks ofdiet treatm,ent.. Levy and colleagues (52) administered a larger glucose bolus
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(6.8 gI BWkg) and found no differences in glucose or insulin measures between HF and
LF rats at 2, 3, 4, or 6 h after the challenge.
In an insulin tolerance study, researchers injected adult male rats, fed HF diets
(39% kcal) for twelve weeks, with .125 VI BWkg insulin after measuring fasting blood
glucose, then monitored blood glu,cose concentrations at 15, 30,60, 120, and 180 min
after the injection. Results demonstrated that animals fed HF diets had delayed BG
responses to the injection. HF rats had significantly higher glucose levels 15 and 30 min
after the injection, and significantly higher overall BG concentrations for the thee h
following the insulin injection, compared to the LF rats (55).
Glycemic clamp studies are an excellent too for assessing insulin sensitivity and
glucose tolerance. In theory, by elevating the level of circulating insulin in animals,
hepatic glucose production is inhibited. Researchers can then measure the amount of
glucose required to maintain euglycemia. Researchers candetennine insulin's ability to
promote glucose disposal from the blood, presumably into muscle cells. This is referred
to as whole-body glucose tolerance or insulin sensitivity (65). The hyperinsulinemic
clamp is the most accurate method to measure insulin resistance.
After 24 ± 1 days ofHF feeding, rats fed 59% ofcalories from fat had similar
basal glucose and insulin levels compared to control-fed animals. HF animals required a
significantly lower rate of glucose infusion to maintain euglycemia during a mid-
physiologic range clamp study (54). In another study,
after feeding 60% ofcalories from fat for four weeks to the same strain ofrat,
however, basal levels of glucose and insulin were higher in treatment animals than
controls. In addition, HF animals required a decreased rate of glucose infusion to
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· maintain euglycemia (17).
In hyperinsulinemic, euglycemic clamp studies, researchers found a significantly
lower glucose infusion rate required to maintain euglycemia in rats fed HF in rats fed HF
diets (59% ofkcal) at three days and three weeks ofdiet treatment. Impaired insulin
sensitivity worsened with the duration of feeding. Compared to rats fed HF diets for thee
days, rats fed the HFdiet for thee weeks required an even lower rate of glucose infusion
compared to controls to maintain euglycemia (51). Similar results have been observed by
other researchers (16;66;67).
Impainnent of insulin-stimulated glucose uptak-e in muscle develops with duration
of HF feeding. After thee days (51) to two weeks (68) ofdiet treatment, muscle glucose
uptake was not different between HF and control animals. After four weeks or more -of
HF diet treatment, insulin-stimulated glucose uptake into muscle was significantly lower
than either control animals or when compared to uptake before HF diets were initiated
(32;54).
Effect ofhigh-fat feeding on body weight and body fat
Studies examining the effects of high-fat feeding on body weight gain in rats show
varied results. This may be due to the effects of rat strain, gender or age, feeding duration,
changes in consumption, or type or quantity of fat in the treatment diets. Researchers
found no differences in body weight post-intervent·on in rats fed between 36% and 90.7%
of calories from fat and control-fed rats on low-fat refined or chow diets
(15; 16;52;54;56;66;68-70). In contrast, other research-ers. have found that adult obesity-
prone and obesity-resistant, as well as young rats, weighed significantly more than
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controls after five to six weeks ofhigh-fat feeding (45% to 65% ofcalories from fat)
(13;32).
Two strains ofmic,e fed a high-fat diet for 1.5 years weighed significantly more
than chow-fed controls, which is consistent with rat and dog models (14;64).
Though HF feeding has not consistently resulted in greater body weight gain in
rats compared to LF controls, in most studies greater than thee weeks' duration, HF
animals had a higher percentage of body weight as fat and had greater visceral fat mass
(13;16;17;52;54;68-70). In rats provided a choice between HF or LF energy sources,
energy intake and body weight of fat preferring rats were not different from carbohydrate
preferring animals in one study (41). In a similar study, body weight of fat-preferring
rats was higher than carbohydrate-preferring animals, despite similar mean daily energy
intake. These researchers attributed the increased body weight to high energy
consumption and weight gain in the HF animals during the first ten days of feeding
compared to high-carbohydrate fed animals (71).
Magnetic resonance imaging (MRI) of female mice fed a HF diet (58% kcal) for
ten months revealed significantly higher visceral and subcutaneous abdominal fat depots
than in LF controls (21 ). Weight gain from consuming HF diets is attributable to an
increase in body fat mass, and not to an increase in lean mass (14).
Effect ofhigh-fat feeding on food intake
Researchers have observed an initial increase in energy and food consumption
when rats are fed diets high in fat (41;71). These findings are not entirely consistent. HF
fed rats consuming 66.5% of calories as fat did not differ in total caloric intake from low-
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fat fed controls over a thee week experimental period (66). Both obesity-prone (OP) and
obesity-resistant (OR) rats fed ad libitum HF diets consumed significantly more calories
during the first week of diet treatment than LF controls. After five weeks of diet
treatment, both OP and OR high-fat fed rats consumed more cumulative energy. In this
study, OP rats consumed greater total energy than OR rats on the same high-fat diet,
indicating that genetics is a co-factor in feeding experiments (13).
Effect of fatty acid composition
The fatty acid composition of the diet has an impact on the development of
impaired insulin sensitivity. In one study, animals fed saturated fat required the lowest
rate of glucose infusion during a glycemic clamp study, while those fed either PUPA with
long-chain n-3.fatty acids or saturated fat with shorter-chain n-3 fatty acids (16 carbons)
required the highest rate of glucose infusion to maintain euglycemia. Although animals
fed a diet ofPUPA alone as the fat source did not significant y differ in insulin sensitivity
from those fed the saturated fat diet, the MUFA-based diet, or the PUFA with 16-carbon
n-3 fatty acids, they did require significantly less glucose to maintain euglycemia than
animals fed either the PUPA plus long-chain n-30r the saturated fat plus 16-carbon n-3
fatty acids (53).
Caloric restriction ofhigh-fat fed animals resulted in significantly decreased
insulin levels for rats fed both safflower oil- and fish-oil-based diets, while those fed a
beef tallow-based diet demonstrated a mild,. nonsignificant increase ·n circulating insulin
levels (72). The level of incorporation ofn-3 fatty acids into the phospholipid port·on of
muscle membranes has been. linked to maintenance ofmuscle insulin sensitivity. Rats fed
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diets high in polyunsaturated fats with the addition of fish oil, which is rich in the n-3
eicosapentanoic and docosahexanoic fatty acids, maintained muscle insulin sensitivity.
The addition of linseed (flax) oil, rich in a-linolenic acid, does not demonstrate the same
protective effect. Linseed oil does, however, exert a protective effect against insulin
resistance when added to diets high in saturated fat. These results indicate that the ratio of
n-6 to n-3 fatty acids in the diet is more important than the total amount ofdietary fat
consumed in affecting glucose tolerance and insulin sensitivity (53).
Insulin sensitivity in humans, as a result ofconsuming high-fat diets, appears to
depend on the total amount of energy provided by dietary fat rather than the source of
dietary fat or the duration of feeding. Among individuals consuming less than 37% of
energy from fat as detennined by food records, those consuming a greater proportion of
saturated fat (SFA) had reduced insulin sensitivity following ninety days of diet than
subjects consuming primarily monounsaturated fat (MUFA) (-12.5% vs. +8.8%
respectively), as demonstrated by intravenous glucose tolerance testing. Among subjects
consuming greater than 37% of energy from fat, both SFA and MUFA intakes were
comparable, lending explanation to the lack of difference in insulin sensitivity between
the SFA fat group and the MUFA group (73).
Introduction to Leptin
In 1973, Coleman (74) described experiments with ob and db mice, which appear
very similar. Both animals are obese, have diabetes, and have markedly increased
concentrations of insulin in the blood. Both are descended from the same genetic strain,
the C57BL/6J mouse. When db/db mice were pararabiosed with non-mutated mice, the
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nonnal mice stopped eating, lost weight, and soon died. When ob/ob mice were
parabiosed with normal mice, both animals of each pair gained weight, and pairs lived
until the time ofnecropsy several months later.
When ob/ob and db/db mice were parabiosed to one another, of the 16 pairs
joined, only one pair survived until the scheduled necropsy four months later. Median
survival time for parabiosed ob/ob to db/db pairs was 26 days. The db/db mice remained
diabetic and obese. They continued to gain weight, had food-engorged stomachs at
necropsy, and were extremely obese. Conversely, the ob/ob mice all lost approximately
15 g, were severely hypoglycemic, and had virtually stopped eating, as they had very little
food in their gastrointestinal tracts at autopsy (74).
Because of the similarity in responses between nonnal and ob/ob mice to
parabiosis with db/db mice, Coleman proposed that a "satiety factor" was at the center of
the phenomena. He suggested that db/db mice produce the factor, but do not respond to
it, and that ob/ob mice have functional "satiety centers" but lack the satiety signal (74).
It was not until 1994 that the satiety factor Coleman suggested was identified and
named leptin.
Leptin
Source and secretion
Leptin, first identified in 1994 by Zhang et al (75), is a 16-kDa peptide hormone
produced in and secreted by adipocytes. In human beings, the serum leptin reference
value of 1 - 16 Jlg/ L is based on the analysis of leptin concentrations of individuals with
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body fat percentages considered to be optimal, which is ~ 15% body fat for men and S
25% body fat for women (6). The reference range for leptin concentrations in rats is 1 -
7.7 Jlg/ L (Linco, St. Louis, MO).
Leptin secretion follows a diurnal rhythm, with highest levels in the blood during
sleeping hours (18). This pattern is evident in obese and lean humans, including those
with DM (19). Studies have demonstrated that leptin secretion is pulsatile in nature, with
pulses occurring approximately every thirty minutes (18;37).
Leptin is believed to be secreted in response to insulin in the blood.
Hyperinsulinemic euglycemic clamp studies perfonned on fasted ovelWeight healthy men
demonstrated that plasma leptin concentrations increased positively in relationship to the
insulin infusion concentration. However, this study also employed glucose infusions to
maintain euglycemia, which precludes conclusion that insulin alone stimulates leptin
release (76). In vitro studies of an adipocyte cell line revealed that leptin is produced by
mature fat cells. Leptin mRNA production is stimulated by the addition of insulin to the
culture media, and suppressed by the insulin removal, as is leptin release from the mature
adipocytes (23). Isolated rat adipose cells cultured with insulin secreted and retained more
leptin than cells of the same animals cultured without insulin (24). Taken together, these
in vitro results indicate that insulin indeed stimulates leptin production and release by
adipocytes.
Circulating leptin levels reflect body fat stores in the well-nourished state. Serum
leptin levels were significantly higher in obese hyperinsulinemic women as compared to
non-obese, non-hyperinsulinemic controls (34). Obese men with untreated type 2 DM
who underwent exercise training and caloric restriction demonstrated significantly
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reduced serum leptin levels after a four-week intervention period. Correlation was found
between BMI and serum leptin at baseline, but was not evaluated at the end of the
intervention (3). A significant positive correlation exists between fasting serum leptin
levels and BMI in obese and normal-weight women, and in Asian Indian men and women
(33;34).
Researchers have detennined a direct linear relationship between circulating leptin
levels and body weight in mice, although the slope of this relationship varies with animal
strain (64). Correlational analysis reveals that log serum leptin positively correlates with
body weight and body fatness regardless of diet treatment (21). Gold thioglucose-obese
mice, characterized by extreme adiposity, had significantly higher serum leptin levels
than lean controls at ten weeks of ad libitum feeding (44.7 ± 3.4 vs. 16.0 ± 1.0 ng/ml,
respectively) (77;78). Leptin levels in male Fischer-344xBN rats were significantly
correlated with multiple fat depot weights at 3, 24, and 31 months of age (78).
Leptin levels also correlated significantly to the Lee index, a mathematica
indicator ofbody adiposity in rodents (r = .92-.96 for ages 3 to 31 months, P < .001).
(78). In a study of lean and obese female Wistar rats, leptin levels were significantly
higher in obese animals than in their lean littermates (28).
Leptin gene expression appears to be dependent on the maturity and location of
the adipose cells. Researchers detennined that isolated mature human adipose cells had
significantly hi-gher leptin mRNA than was determined in adipose tissue which contained
both mature and immature cells, and that subcutaneous fat cells express significantly
more leptin mRNA than those from visceral stores (35). In all subjects ofone study,
leptin mRNA levels were significantly higher in subcutaneous adipose tissue than in
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visceral stores (36).
Gender may also be an i.ndependent predictor of leptin in the blood. In infants
twelve months of age and younger, girls had higher plasma leptin levels than boys, even
after correction for BMI (37). Boys' and girls' serum leptin concentrations reflected the
same dichotomy at similar body weights from ages 5 though 15 (38). Analysis by
bioelectrical impedance analysis and DXA confirm that women have higher circulating
leptin levels than men at equal BMI, body weight, body fat mass, and body fat percent
(33). This could be associated with the finding that women have a higher mean ratio of
subcutaneous-to-omental fat than men (36).
Some researchers have identified a relationship between age and leptin levels in
the blood, although the significance of this relationship is unclear, except in species
known to increase in adiposity with age, such as rats. Age was a predictor of leptin levels
in babies only between one and six months of age (20). In children between five and
fifteen years of age, girls exhibited a steady increase in serum leptin levels with age. Boys
demonstrated an increase in serum leptin concentrations until age ten, after which levels
fall steadily (38). Age was not correlated significantly with leptin in adult men and
women (33). Fischer 344xBN rats' serum leptin levels were significantly increased with
age, from 3 to 24 to 31 months of age (78).
Leptin's relationship with age in young mammals may be related to its role in
sexual maturation. In young girls, serum leptin concentrations rise steadily from
prepuberty though mid-adolescence and the onset of reproductive function. The rise in
leptin levels is similar in boys, until testosterone levels begin to increase, at which time
leptin concentrations begin to steadily decline (38).
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Although leptin reflects adiposity, this reflection is disrupted with fasting and
negative energy balance. In male rats fasted for 48 h with access to water, serum leptin
levels and body weight ,declined significantly as compared to controls maintained with ad
libitum feeding (78). Obese men with untreated type 2 DM who underwent weight loss
though exercise training and caloric restriction demonstrate,d significantly reduced serum
leptin levels after a four-week intervention period (3).
Leptin inhibits the secretion ofhypothalamic neuropeptide Y, an appetite
stimulant, in the brain. Fasted female mice exhibited decreased leptin levels following a
48-h fast, as compared to non-fasted control mice (21). This effect was also evident in
healthy adult ~omen in the first day of a four-day fast (79).
Previously, HF diets were shown to increase body fatness. Expressed as a
percentage of eviscerated carcass weight, researchers detennined there was a direct
relationship between serum leptin levels and body fatness in rats after HF feeding (57).
Fish oil- and safflower oil-fed rats had significantly higher circulating leptin
concentrations and smaller perirenal fat mass and cell size than animals fed a beef tallow-
based diet which provided the same amount of energy and fat. When energy intake was
decreased to 85% ofad libitum by removal of carbohydrate from the diet, leptin levels
decreased in animals on both the fish oil and safflower oil diets to concentrations
comparable to ad libitum-fed rats on tIle saturated fat diet, but not in those rats fed the
tallow-based diet (72).
The effects ofHF feeding on leptin levels in the blood are also inconsistent from
study to study. Two separate experiments by the same researchers indicate an immediate
effect ofdiet on serum leptin levels in mice, with significantly greater areas un,der the
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curve for both the first and second days of high-fat diet tre~tment as compared to low-fat
fed controls· (134.6 ± 10.3 vs. 100.0 ± 12.3, P = .028 for day one, and 126.5 ± 8.2 vs.
100.0 ± 5.2, P + .016 for day two) (80). While some researchers found significantly
increased fasting leptin levels in HF rats (15;32), others found no differences in either
fasting levels of leptin or in leptin responses to IVGTT following a 6.8 g/kg ·BW glucose
load versus controls (52). Other researchers have found similarly inconsistent results in
non-fasted rats. HF rats fed both ad libitum and at a restricted-calorie level had
significantly higher serum leptin levels.than ad libitum chow-fed controls (68). Steinberg
and Dyck found that HF rats had higher serum leptin levels than controls after four weeks
(70), as did others after only ten days of feeding (15). Researchers have also found
significantly higher plasma leptin levels after four weeks ofHF feeding, but this effect
did not persist to fourteen weeks of diet treatment (69). When nonnalized per gram of
body fat, HF rats had significantly greater leptin levels than LF rats in one study (70), but
the reverse was found in another (69).
Leptin serves as a messenger to the brain from the adipose cells, indicating energy
balance. Within the brain, leptin binds receptors in the ventromedial hypothalamus,
thereby inhibiting production ofneuropeptide Y, a polypeptide known to stimulate
appetite. In male rats fasted 48 h, serum leptin levels and body weight declined
significantly, and hypothalam·c neuropeptide Y mRNA levels significantly increased as
compared to controls maintained with ad libitum feeding, an expected result given the
relationship between leptin, body weight, and neuropeptide Y (78).
Leptin has been ljnked with postprandial satiety and subsequent meal intake. In
the postprandial period, leptin levels increase, then dec ine somewhat inmost subjects,
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triggering an increase in hunger and soon followed by the request for the next meal in
subjects fed ad libitum and deprived of time cues. Leptin levels at the time ofmeal onset,
however, are not associated with energy intake at the meal (37). Animal research
indicates that administration of leptin to both female and male rats reduces 24-h energy
intake up to 20% by reducing meal size (29;30). Researchers demonstrated that
intracerebroventricular leptin injection significantly inhibits food intake in rats by
injecting 0.4, 1.0, and 4.0 Jlg of murine leptin and observing total food intake for the
following 22 h. Reductions in food intake, as compared to vehicle-injected controls,
increased as dose increased (15%, 26%, and 4'0% reductions in intake for 0.4, 1.0, and 4.0
Jlg doses, respectively), though the linearity of the relationship was not evaluated (31).
Intraperitoneal injection of 1 mg leptin reduced rats' food intake by 26% as compared to
control rats over the 22 h following the injection (31).
Moderate hyperleptinemia in rats, induced by injection of a recombinant
adenovirus containing rat leptin cDNA significantly decreases ad libitum caloric intake in
both high-fat fed and chow-fed animals versus non-treated controls on the same diets
(42.61 ± 2.7 kcal/d vs. 93.3 ± 0.9 and 35.45 ± 1.6 vs. 95.9 ±0.6, respectively). Induced
hyperleptinemia decreases caloric intake significantly more in chow-fed rats than HF rats
-(32). Weight loss was marked in chow-fed hyperleptinemic animals as compared to
chow-fed, calorie-matched, non-hyperleptinemic rats injected with a adenovirus that does
not affect leptin production. Weight loss in high-fat fed hyperleptinemic rats was not
significant compared to non-hyperleptinemic high-fat fed animals (32).
In an attempt to minimize the appetite-suppressing effects of leptin
administration, researchers injected high-fat fed rats daily with a 1 mg! BWkg dose of
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· leptin at the beginning of the light cycle, and found that weight was reduced by 8% after
four days ofhonnone administration as compared to high-fat fed, non-Ieptin treated
animals (68).
Hyperleptinemia produces significantly greater visceral fat mass reductions in HF
rats than in calorie-matched, non-hyperleptinemic animals fed the same diet well as
hyperleptinemic animals fed chow (44 ± 6 vs. 20 ± 2 and 40 ± 5, respectively). Rats
treated with recombinant mouse leptin for eight days had significant ydecreased visceral
fat mass (pooled epididymal, perirenal, and mesenteric fat pads) compared to control rats
(32). Similar decreases were observed in rats subjected to caloric restriction for the same
period of time. In addition, leptin-treated and caloric-restricted rats demonstrated a
significantly decreased rate of glycogenolysis compared to controls (81).
The ratio of fatty acid (oleate) esterification to oxidation in both soleus and
extensor digitorum longus muscle was significantly reduced by treatment with leptin as
compared to both insulin-treated and untreated muscles of the same type, and compared
to muscle fibers treated with both insulin and leptin (82). In isolated muscle cells from
ob/ob mice and their lean littermates, leptin treatment increased radiolabeled fatty acid
(oleate) oxidation significantly compared to non-treated contralateral muscles (15% to
30%), and decreased the incorporation of fatty acid into triacylglycerol by as much as
30%. Treating muscles simultaneously with leptin and insu in resulted in a net
cancellation of-insulin's fat-storing effects (82).
Researchers found no significant differences in either exogenous palmitate
oxidation or esterification into triglyceride between high fat fed or control animals'
muscle fibers treated with leptin. However, leptin-treated muscle fibers of ow-fat fed
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animals exhibited a significantly higher mean exogenous p~lmitate oxidation rate
compared to untreated soleus muscle fibers of the same treatment group (70).
A possible explanation exists for the seeming failure of leptin to inhibit appetite in
obesity, whether genetic or diet-induced. Human and animal research indicates leptin
transport mechanisms at the blood-brain barrier are easily saturated. High-fat fed lean
Zucker FAIFA and energy-restricted genetically obese Zucker fa/fa rats had similar levels
of radio-iodinated leptin in all regions of the brain following radiolabeled leptin injection
into the branchial vein. Despite similar levels of leptin in cerebrospinal fluid, these levels
were significantly lower than those found in lean, low-fat fed Zucker FAiFA rats (83). In
an experiment to mimic leptin transport at the blood-brain barrier, isolated human brain
capillaries incubated for 120 min with iodinated leptin and then acid-washed
demonstrated significant leptin incorporation into the endothelial membrane, which
persistently increased over the incubation period at 37°C. Brain capillary plasma
membranes incubated similarly and in the presence of insulin, exhibited binding and
incorporation into the membrane which appeared to be saturable as leptin concentration
in the media increased, and was not affected by the presence of insulin (84).
Researchers found that obese individuals with a mean serum leptin concentration
that was 318% higher than nonnal-weight subjects had only 30% higher concentrations of
leptin in cerebro-spinal fluid (CSF), another possible explanation for th'e seeming
resistance to hyperleptinemia in obesity (85).
Gold thioglucose-injected obese mice demonstrated significant y reduced serum
glucose and insulin level~ two-hours after a 25 Jlg intraperitoneal injection of
recombinant mouse leptin, as compared to lean leptin-treated and gold thioglucose- .
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treated, leptin-untreatedanimals (77). In a study using pancreatic INS-I insulinoma cells,
researchers found that leptin concentrations of20 nmoVI had no influence on insulin
release in response to 10 mmol/l glucose stimulation in relation to cells not exp-osed to
leptin. Similar results were found at a non-stimulatory glucose concentration of 3 mmoVl
in conjunction with leptin concentrations ranging from .5 to 50 nmol/l. These researchers
also found that in the presence of agents that raise intracellular levels of cAMP, leptin
does inhibit the secretion of insulin in response to glucose (25).
There is relationship between endogenous leptin levels in the blood and insulin
resistance or sensitivity. Researchers found a significant positive correlat·on between
degree of insulin resistance and circulating leptin levels in a study of22 lean and obese
insulin sensitive (IS) and insulin resistant (IR) subjects (2).
In rats subjected to intravenous glucose tolerance tests (NGTT), leptin infusion
decreased basal insulin and triglyceride levels in the blood, as well as significantly
decreased the insulin response to the glucose bolus (27). Leptin infusion at rates of 0.1,
0.5, and 5 Jlg/ BWkg-1/ minute during a hyperinsulinemic, euglycemic clamp study in rats
produced rapid decreases in plasma insulin levels. The dose-response relationship
between leptin and insulin was significant at r = -0.731 (25).
Cultured rat hepatocytes and adipocytes treated with leptin exhibited significantly
reduced insulin binding as compared to untreated cells, demonstrating that leptin inhibits
insulin binding at the cellular level (28).
Adipocytes cultured in 50 nM of leptin bound 19% less 125I-Iabeled insulin than
non-Ieptin treated cells, and binding was reduced by 24% compared to untreated cells at
leptin concentrations of 2.5 JlM in culture (26). Leptin concentrations of 20 nrnol/ L did
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· not inhibit glucose-stimulated insulin release from cultured pancreatic IN·S-I ~-cells, but
did inhibit insulin release stimulated by other honnones (25). In isolated mouse muscle
fibers, leptin induced fatty acid oxidation prevented by insulin in leptin's absence (82). In
the absence of insulin, leptin had no effect on cellular metabolism in culture, but did
inhibit insulin-mediated glucose metabolism and lipogenesis and stimulate lipolysis in
insulin-stimulated conditions (86).
Rats treated with daily 1 mg/ BWkg injections ofleptin for four days at the end of
a 28-day high-fat feeding trial exhibited significantly reduced insulin-stimulated muscle
glucose uptake as compared to control chow-fed rats, but significantly greater uptake as
compared to rats on the same high-fat (50% ofcalories) (68).
Both high-fat- and chow-fed rats treated with a recombinant adenovirus to
produce moderate hyperleptinemia exhibited significant decreases in plasma glucose and
insulin levels as compared to HF, calorie-matched (to high-fat, hyperleptinemic rats)
animals treated with a control adenovirus (glucose levels 135.7 ± 6.7 and 112.25 ± 12.5
mg/dl respectively, vs. 156.5 ± 5.5 mg/dl, P < .05, and insulin levels .64 ± .21 and .23 ±
.1 ng/ml vs. 3.79 ±.7 ng/ml) (32).
Eight days of recombinant mouse leptin administration to male rats resulted in
decreased food intake, which was associated with improved fasting glucose tolerance and
insulin sensitivity, as evidenced by significantly lower fasting insulin leves but similar
fasting glucose-levels in leptin-treated rats as compared to untreated control rats and
calorie-restricted rats that lost a similar amount ofweight. Hyperinsulinemic, euglycemic
clamp results indicate that leptin-treated rats' insulin-stimulated glucose uptake was
significantly higher (63%, P < .001) than that ofcontrols and calorie-restricted rats that
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had lost similar amounts of visceral fat. This increase in glucose uptake is attributable to
both increased glycogenesis and glycolysis (81).
Growth Honnone and Insulin Resistance
Growth Honnone (GH) is produced and released from the pituitary gland within
the mammalian brain. Its production is stimulated by Growth Hormone Releasing
Honnone, which is produced in and secreted from the hypothalamus (87). GH stimulates
growth of lean body mass (42). Deficiency results in excess body fat accumulation (88),
while excess stimulates hypertrophy and hyperplasia (50). GH concentrations in the blood
exhibit a circadian rhythm, with elderly individuals demonstrating peak GH
concentrations during late waking hours, and younger probands exhibiting peak
concentrations during sleeping hours (48). In female rat pups, median GH secretion is
high, and median plasma GH levels fluctuate with aging, with concentration ranges
within age exhibiting a wide range, and pulsatile secretion fluctuating every 2 to 4 hours
(47). GH influences lipid metabolism at the tissues (89). Researchers found that
exogenous GH administration increased both abdominal and femoral adipose interstitial
glycerol, free fatty acid, and 3-0H-butyrate concentrations compared to saline
administration. GH is associated with increased glucose-stimulated insulin secretion
during puberty (90), and is inversely associated with pubertal insulin sensitivity (45).
Growth honnone administration in deficient subjects is associated with increases
in lean body mass and reductions in body fat mass without significant changes in BMI.
This shift in body composition is associated with decreased serum leptin levels and
increased circulating insulin levels in both adults and children (43).
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Exogenous GH treatment or endogenous GH excess results in impaired insulin
sensitivity or insulin resistance. Acromegalic patients, who hypersecrete GH, hypersecrete
insulin and exhibit impaired insulin sensitivity compared to nonnal weight, normal GH
controls, but not when compared to weight-matched subjects, indicating a similarity in
the metabolic changes ofobesity and excess GH (50). In GH deficient children receiving
GH treatment who developed IGT or type 2 DM,approximately one third of those who
stopped GH treatment experienced improvements in glucose tolerance following
cessation of GH treatment. Children between the ages of 6 and 19 years receiving GH
treatment were also found to be at increased risk ofdeveloping type 2 DM (91).
Administration of a single bolus of exogenous GH in humans induces a
significant acute increase in serum leptin concentrations within 24 h, followed by a
significant decrease in leptin concentrations within 72 hours of the injection, without a
change in body composition (17). Similarly, researchers found that two and a half days of
twice daily injections of 1 gmI BWkg GH in rats had no effect on fasting plasma glucose
or glucose tolerance, but increased fasting plasma insulin levels by 65% and insulin
response to a glucose load by 35%(90) (92).
The effect of administration of GH on insulin sensitive individua s without pre-
existing metabolic conditions is equivocal. In young men, a single 200 Jlg intravenous
injection ofGH intended to mimic a physiologic pulse to produce an increase in serum
GH did not produce any alterations in serum insulin, glucose, or glucagon over the
ensuing 6 h (89). Growthhonnone administration in nonnal subjects to achieve levels of
30 to 35 nglmL did not change fasting insulin or glucose levels, but increased glucose-
stimulated insulin secretion and reduced insulin sensitivity following an oral glucose
29
challenge (46).
Under non-hyperinsulinemic glycemic clamp conditions, GH infusion had no
effect on plasma insulin- and glucose in rats compared to controls receiving a saline
infusion. When hyperinsulinemic euglycemia was induced following the elevation in GH
for the subsequent 150 minutes, growth honnone infused rats required a significantly
lower rate of glucose infusion to maintain euglycemia for 220 min and later. This
decrease in insulin-stimulate glucose uptake reached 37% by 5 h after initiation of the GH
infusion. In the already insulin-stimulated state, initiation of GH infusion resulted in a
32% decrease in insulin-stimulated glucose uptake, which reached significance 180 min
afterGH infusion began. This effect of GH infusion was due mainly to suppression of
peripheral insulin sensitivity and not of hepatic glucose output (39).
Although a significant positive correlation did exist between GH concentrations in
plasma and the degree of insulin resistance in one study, circulating GH levels of insulin
resistant obese subjects (mean BMI 30.3 ± .8 kglm2) did not differ significantly from
obese and non-obese insulin-sensitive controls (mean BMI 25.9 ± .3) (2).
Newly diagnosed obese/ overweight Chinese subjects with type 2 DMhad
significantly lower plasma GH concentrations than nonnal weight, nondiabetic controls.
In this study, plasma growth honnone was significantly negatively correlated with waist
circumference; this significance was eliminated when BMI was controlled for (4).
GH concentrations seem to be sensitive to negative energy balance in humans and
rats. In adolescent wrestlers, intentional weight loss prevented an expected increase in
GH secretion compared to non-weight-restricting controls. GH ,concentrations
nonnalized when weight restriction ceased, and growth then increased, compensating for'
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the lack ofgrowth during weight restriction (49). Rats fasted for 20 h exhibited
suppressed GH peak secretion (47). In contrast to rats, hypoglycemia induced by
hyperinsulinemic glucose clamp, resulted in significant increases in GH levels in men and
women. Hypoglycemia, clamped at 70 mg! dL, induced an II-fold GH increase in men,
and a nearly 4-fold increase in women compared to nonnalfasting glycemia (90 mg!dL).
Further decreases in blood glucose concentrations resulted in further increases in GH
concentrations in both genders, with significantly greater GH levels in men than in
women (93).
The effects of induced GH deficiency are not consistent between studies. In vivo
GH administration by minipump produced significant reductions in basal glucose
transport in adipocytes at 50 mU/ day with as little 12 h of infusion (40). Treatment with
GH antiserum reduced growth honnone and insulin levels in vivo, as well as increased
the in vitro rate of lipogenesis in adipose cells isolated from rats treated with the
antiserum. When GH was administered to GH-depleted animals, these effects were
reversed (94). Isolated adipocytes from GH deficient rats exhibited significantly increased
glucose uptake and lipogenesis when incubated for 1 ,3, or 6 h with anti-rat GH serum as
opposed to that of cells incubated with non-immune serum. When incubated-in the
presence of insulin, this increased glucose utilization persisted in antibody-treated cells,
but was not enhanced by the addition of insulin more than in non-antibody-treated cells
(95).
In summary, overweight and obesity are growing health concerns in industrialized
nations such as the US, where caloric intake is increasing and physical activity is
decreasing, especially among the young (9). Excess body weight and body fatness
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contributes to health conditions such as heart disease, dyslipidemias, and type 2 diabetes
mellitus.(96) High-fat diets providing excess energy contribute to increased body weight
and body fat accumulation, impaired glucose tolerance and insulin resistance in
laboratory animals and humans, but the mechanism by which this occurs is not clear
(14;51 ;54;55;62;68). Body fat is positively correlated to leptin concentration, which is
positively correlated to insulin resistance and negatively correlated to insulin-stimulated
glucose uptake (21 ;22). Type 2 diabetes, characterized by insulin resistance and impaired
glucose tolerance, frequently is not diagnosed until overt symptoms such as weight loss,
increased appetite, and frequent urination develop (6).
Diets high in fat are known to increase body weight and fat mass, induce
alterations in carbohydrate and lipid metabolism, lead to insulin resistance, and increase
production and release of the honnone leptin in humans, rodents, and other animals (13-
17).
Obese individuals produce twice the amount of eptin compared to slender
individuals, and there is evidence indicating this is due to increased production of leptin
by subcutaneous adipocytes compared to visceral fat cells (35;36).
This study examines the development of impaired insulin sensitivity in female rats
fed high fat diets during rapid growth and sexual maturation.
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CHAPTER ill
MATERIALS AND METHODS
Animals
This research project was approved by the Institutional Animal Care and Use
Committee of Oklahoma State University, Stillwater, under protocol number HE 01-16
(Appendix B).
Twenty female weanling Sprague-Dawley rats (Harlan Sprague-Dawley,
Indianapolis, IN) were randomly assigned to one of two diet treatments. Animals were 21
days of age on arrival, and were housed individually in hanging steel cages. Body weight
(BW) in grams was recorded on arrival, and weekly thereafter. Animals were fed their
assigned diets on the day of arrival and for the duration of the study. All animals had free
access to deionized water and were kept on a 12:12 light: dark cycle (lights on at 0700).
Diet Treatments
Diet composition and energy value are outlined in Table 1. The diet treatments
differed in fat and carbohydrate content. The LF diet contained 10% fat by weight, and
the HF diet 20% fat by weight. Both diets were prepared to provide an equal amount of
vitamins and minerals per calorie, and contained equal percentages ofprotein and fiber by
weight. Energy requirements for young growing rats (3 to 7 weeks of age) is at least 227
kcal/ BWkg 0.75 per day, while the energy consumption ofmature (> 7 weeks of age) rats .s
calculated at 150 kcall BWkg 0.75 per day (97). Based on a projected weight of 100 g at 5
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weeks of age, the maximum expected energy requirement during the first 2 weeks of
feeding trial was 40 kcal per day. Based on a projected BW of250 g by the end of the
study, maximal daily energy requirements for the animals were calculated to be 53 kcal
per day. Animals were intentionally provided excess food energy during this study. For
the first 2 weeks, animals received 53 ± 0.5 kcal (13 g LF diet and 11.7 g HF diet) per
day. After 2 \veeks of diet treatment, when at least half of the animals were consuming
100% of the food provided, the amount ofdiet was increased to 65 ± 0.5 kcal (15.85 g LF
diet and 14.22 g HF diet) per day-. Food intake was measured for 24 h preceding each
DXA measurement for 3 or 4 animals in each treatment group.
Glucose Tolerance Tests
After 5 weeks ± 1 day of the feeding trial, when the rats were 8 weeks of age and
had an average weight 166 g, an oral glucose tolerance test was performed on animals
(OGTT #1) following an overnight fast. Free access to de-ionized drinking water was
allowed during the fast. On the morning of the OGTT, animals were weighed, then
approximately 1.0 mL ofblood was collected via the tail vein. Blood glucose was
detennined using a DEX glucometer (Bayer Corporation, Elkhart, IN). Each animal was
then gavaged with 2 g glucose/ BWkg. The time at which the gavage was given was
recorded as "Zero hour." One mL blood samples were then taken from the tail vein 30,
60, and 120 min after glucose administration. The first drop of blood at each collection
time was used to detennine blood glucose using the DEX. Blood samples were collected
into polypropylene microcentrifuge tubes and kept on ice until processing. Glucose
tolerance tests were repeated at two-week intervals, at 10 and 12 weeks of age (OGTT #2
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and OGTT#3, respectively), with average weights 191 ± g and 211 ±g, respectively. The
glucometer was calibrated on each day of glucose tolerance testing. The inter-assay
coefficient of variation (CV) for glucose was 5%.
Dual X-ray Absorptiometry
At 6,8, and 10 weeks of treatment (when 9,11, and 13 weeks of age), animals
were sedated with 58 mg! BWkgketamine Hel and 2.9 mg! BWkg-xylazine. A model 4500
Elite Dual X-ray Absorptiometry machine (DXA, Hologic, Waltham, MA) was then used
to estimate body fat mass and lean body mass.
Necropsy, Blood and Tissue Collection
-On the day of the final DXA scan, animals were necropsied following the scan,
and exsanguinated via the abdominal aorta. Liver, heart, right soleus muscle, and fat were
harvested and placed in labeled cryovials, then snap frozen in liquid nitrogen and stored
at -800 c.
All blood samples were kept on ice for a minimum of 30 min before
centrifugation (Jouan, Inc., model CR-3i) at 3300 x g for 15 min. Serum was aliquoted
into labeled tubes. Serum insulin and leptin were determined by radioimunoassay (RIA,
Linco Research, Inc., St. Charles, MO). Intra- and inter-assay coefficients of variation
(CV) were 10.3% and 7.8% for insulin, 7.1 % and 7.4% for leptin, respectively. All GH
samples were analyzed in one assay, with an intra-assay CV of7.0%.
Area under the curve was calcula~edfor glucose, insulin, and leptin responses to
each glucose to crance test by summing the areas under each consecut·ve blood or serum
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observation using the fonnula:
Statistical Analysis
SAS Version 8 Statistical Analysis Software for Windows was used to analyze all
data. Data outliers indentified by the Univariate procedure, which defines outliers ~
being greater than 1.5 interquartile ranges from the 25th to the 75th interquartile were
excluded. The Mixed procedure was used to determine significant main effects and their
interactions, with the Slice procedure used to determine differences between groups.
Pearson correlation coefficients were determined using the Corr procedure. The level of
significance (n) was set at p ~ 0.05.
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Table 1. Composition and energy value of experimental ,diets.
Low-fat diet
glkg Diet
Casein 200
Cornstarch 100
Sucrose 500
Cellulose 50
Soybean oil 100
Mineral mix*t 35
Vitarnin mixt t 10
L-Cysteine 3
Choline Bitartrate 2
%kcal
High-fat diet
200
100
400
50
200
39.3
11.2
3
2
CHO
Fat
Protein
Energy Density
58
22
20
4.10
kcall g diet
43
39
17
4.57
* Mineral mix composition is detailed in Appendix B.
t Teklad vitamin mix, catalog #40060.
t Amounts of mineral and vitamin mixes in the high-fat diet were adjusted to equal the
amounts per calorie in the low-fat diet.
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CHAPTER IV
EFFECT OF HIGH-FAT DIET ON BODY COMPOSITION AND
HORMONE RESPONSES TO GLUCOSE TOLERANCE TESTS
Abstract
This study examines the effect of high-fat diet on glucose tolerance, blood
glucose and insulin responses to a 2 g/ BWkg oral glucose challenge, as well as the role of
leptin in the development of insulin resistance. Growth honnone (GH) was measured to
elucidate whether GH is involved in_ the development of diet-induced insulin resistance
during growth. Twenty weanling female Sprague-Dawley rats were randomly assigned to
a high-fat (HF, 39% of calories) and low-fat (LF, 22% of calories) diets. Oral glucose
challenges were administered following 5, 7, and 9 weeks on the feeding trial. Animals
were provided diet in excess of their requirements for growth. Body mass analysis was
conducted by dual X-ray absorptiometry (DXA) on the 6th, 8th, and 10th weeks of the trial.
HF animals gained more weight after 7 weeks, had greater body fat than the LF animals,
and similar glucose responses to the oral glucose challenges. HF rats secreted more
insulin and leptin compared to LF animals. Lean body mass and GH concentrations were
not different between the groups. Results of this study demonstrate that leptin but not GH
is involved in the development of insulin resistance in growing rats as a result of excess
energy intake in the fonn ofdietary fat.
38
Introduction
Overweight and obesity are growing health concerns in industrialized nations
such as the USA, where caloric intake is increasing and physical activity is decreasing,
especially among the young (1). Excess body weight and body fatness contributes to
health conditions such as heart disease, dyslipidemias, and type 2 diabetes mellitus (2).
Obese individuals produce twice the amount of leptin compared to slender individuals,
and there is evidence indicating this is due to increased production of leptin by
subcutaneous adipocytes compared to visceral fat cells (3;4). (5-9)
Body fat is positively correlated with leptin concentration, which is positively
correlated to insulin resistance and negatiyely correlated with insulin~stimulatedglucose
uptake (10).(11) Frequently, type 2 diabetes, which is characterized by insulin resistance
and impaired glucose tolerance, is not diagnosed until overt symptoms such as weight
loss, increased appetite, and frequent urination develop (12).
Diets high in fat are known to increase body weight and fat mass, induce
alterations in carbohydrate and lipid metabolism, lead to insulin resistance, and increase
production and release ofleptin in humans, rodents, and other animals (5;13-16). High--
. fat diets providing excess energy contribute to increased body weight and body fat
accumulation, impaired glucose tolerance and insulin resistanc·e in laboratory animals and
humans, but the mechanism by which this occurs is not clear (17).
D·uring puberty, growth hormone (GH) is associated with increased glucose-
stimulated insulin secretion (18), and is inversely related to pubertal insulin sensitivity
(19). OH secretion is pulsatile iIi nature, with fluctuations occurring in rats every 2. to 4
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hours (20). This study was designed to examine the effects ofHF diets in promoting
impaired insulin sensitivity in female rats during rapid growth and sexual maturation.
Materials and Methods
Twenty female weanling Sprague-Dawley rats (Harlan Sprague-Dawley,
Indianapolis5 IN) were randomly assigned to one of two diets (Table 1). Animals were 21
days of age on arrival, and were housed individually in suspended wire bar-floor cages.
Body weight (BW) in grams was recorded on arrival, and weekly thereafter. Animals
were fed their assigned diets on the day of arrival and for the duration of the study. All
animals had free access to water and were kept on a 12:12 light: dark cycle (lights on at
0700).
Diet composition and energy value are outlined in Table 1. Diet treatments were a
10% fat by weight diet (LF) and a 20% fat by weight diet (HF). Both diets were prepared
to provide equal vitanlins and minerals per calorie, and contained equal percentages by
weight of protein and fiber. Based on a projected weight of 100 g at 5 weeks of age, the
maximum expected energy requirement (21) during the first 2 weeks of feeding trial was
approximately 40 kcal/ day. Based on a projected BW of250 g by the end of the study,
maximum daily energy requirements for the animals was calculated to be 53 kcal/ day.
Animals were intentionally provided calories in excess of energy requirement for this
study. For the first 2 weeks, animals received 53 kcal per day. After 2 weeks ofdiet
treatment, diet was increased to provide 65 kcal per day. Food intake was measured 24 h
preceding each DXA measurement for 3 or 4 animals in each treatment group.
After 5, 7, and 9 weeks of treatment diets, oral glucose tolerance tests (OGTT)
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were administered to animals following an overnight fast. Free access to deionized
drinking water was allowed during the fast. On the morning of the OGTT, animals were
weighed, then approximately 1.0 mL of fasting blood was collected via the tail vein.
Blood glucose was determined using a DEX glucometer (Bayer Corporation, Elkhart,
IN). Each animal then received 2 g glucose/ BWkg by gavage. Blood samples were taken
from the tail vein at 30, 60, and 120 min after the glucose administration. The first drop
ofblood at each collection time was used to detennine blood glucose concentration using
the DEX. The glucometer was calibrated on each day of glucose tolerance testing, and all
calibrations were within the acceptable range. The inter-assay coefficient of variation for
glucose was 5%.
At 6, 8, and 10 weeks of diet treatment (when rats were 9, 11, and 13 weeks of
age), animals were sedated with 58 mg! BWkgketamine Hel and 2.9 mg/BWkg xylazine
for body composition analysis. A model 4500 Elite Dual X-ray Absorptiometry machine
(DXA, Hologic, Waltham MA) was then used to detennine body fat mass, percentage of
body fat, and lean body mass. Animals were necropsied following the last DXA, after 10
weeks of diet treatment.
Serum insulin, leptin, and growth honnone (GH) were detennined by
radioimunoassay (RIA, Linco Research, Inc., St. Charles, MO). Intra- and inter-assay
coeffecient of variation (CV) were 10.3% and 7.8% for insulin, 7.1% and 7.4% for leptin,
respectively. GH was analyzed in a subset (n = 16) of the animals studied. Intra-assay CV
for GH was 7.0%.
SAS Version 8 Statistical Analysis Software for Windows was used to analyze all .
data. The Mixed procedure was used to determine significant main effects and their
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interactions, with the Slice procedure used to detennine differences between groups.
Pearson correlation coefficients were determined using the Corr procedure. The level of
significance (a) was set at p~ 0.05.
Results
Body weights of rats in both groups were not different until after the seventh
week of diet treatment. After the seventh week of diet treatment, HF animals weighed
significantly more than LF animals (P < .05, Fig. 1). HF rats had significantly higher
body fat percent (fig. 2), as well as body fat mass than LF rats. Lean body mass was not
different between groups throughout the experiment (fig. 3). Food energy intake was not
different between groups. Table 2 shows a comparison between groups for body fat
percent, body fat mass, lean body mass, and food intake over time. .
No significant differences in blood glucose levels between groups at fasting or in
response to the oral glucose challenges were observed at all time points. Area under the
curve (AVe) for blood glucose response was not different between groups. In the HF
group, blood glucose concentrations peaked at 60 min after each glucose challenge, while
glucose concentrations seemed to plateau between thirty and sixty minutes post-challenge
in the LF group. Rats in both groups exhibited a failure of blood glucose to return to
fasting levels two hours after the glucose load (fig. 4)..
Fasting serum insulin concentrations at both the OGTT 2 and OGTT 3were higher
(p < .05) in the HF group than in the LF gro~p. Insulin levels were significantly higher (p
< .05) in the HF group at 30 min during OGTT 1 and at 120 min during OGTT 2. During
the OGTT 1, peak insulin response in LF rats was at 60 min compared to HF, although
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this delay in insulin response did not persist to subsequent OGTTs. The insulin response
AVe for the OGTT 1 and OGTT 2 were significantly greater (p < .05) for HF rats than
LF rats, with a tendency for significance (p < .1) at OGTT 3 (fig. 5).
Mean serum leptin concentrations in response to OGTT 1 were significantly
greater (p < .05) at 30 min and 2 h after the glucose load was administered. Serum leptin
concentrations at OGTT 2 were higher in the HF animals 2 h after the glucose challenge
(p < .0001). At OGTT 3, serum leptin levels of the HF rats were significantly greater (p <
.001) at 1 h and 2 h after glucose administration. The serum leptin AUC was greater in
HF rats at OGTT 1 and OGTT3 (p < .05 and p < .001, respectively). Leptin AUC was not
significantly different between groups during OGTT 2 (fig. 6). No differences were found
between groups in serum growth honnone responses at any time point of any glucose
tolerance test (data not shown).
Significant positive correlations were observed between body weight and fasting
insulin at all OGTTs (range: p < .02 to P < .0006) and with fasting leptin concentrations
at OGTT 1 (p < .05) and OGTT 3 (p < .05). Percent body fat throughout the study was
positively correlated (range: p < .02 to p < .0001) with fasting insulin and with fasting
leptin concentrations at OGTT 1 with DXA 1 (p < .002), OGTT 3 to DXA 2 (p < .05) and
OGTT 3 to DXA 3 (p < .01). Fasting leptin and insulin concentrations were positively
correlated at OGTT 1 (p < .0009) and OGTT 3 (p < .004). Body weight was significantly
correlated with percent body fat at DXA 2 and DXA 3. All significant correlations in this
discussion are found in Table 3 (complete correlation tables are in Appendix D).
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Discussion
This study was undertaken to detennine the relationships between body
composition and certain honnones in the development of diet induced insulin resistance.
The HF diet was designed to resemble the total fat content of the typical American diet
(1).
The increased body weight ofHF rats over LF rats is not explained by energy
consumption, as the total cumulative difference in energy intake between groups, based
on mean intake for each group, is calculated to be 22.4 calories, approximately the
equivalent of two grams ofbody fat. Researchers have described HF rats which gain a
disproportionately greater amount ofbody weight than would be expected based on
energy intake (13;22). This increased energy efficiency may be due to a lack of increased
heat production post-feeding in the HF rats, as was seen in a study conducted by Storlien
and colleagues (6). Others have suggested that storage of ingested fat requires less energy
than conversion of consumed carbohydrate into fat stores (23). Such differences in
macronutrient partitioning may account for the increased body weight without evidence
of increased energy consumption.
Our finding that HF rats consumed equivalent amounts of energy to LF rats is
consistent with the finding that HF rats' caloric intake is not increased over that of
controls (24). However, others have described increased initial energy consumption in
SD rats fed HF diets compared to LF fed animals, which accounted for increased body
weight that was evident early and persisted beyond the point that energy consumption
equalized between groups (25). The difference in body weight between groups in this
study was not evident before the seventh week ofdiet treatment, therefore, it is doubtful .
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that initially increased energy intake in HF rats is the cause of the body weight disparity
betwe,en groups.
HF rats in this study accumulated significantly greater fat mass than LFanimals
before significant increases in body weight were detected. Findings such as these were
evident in male rats fed HF diets from 6 to 18 weeks of age (26). The increased body fat
in HF animals, coupled with no difference in lean body mass between groups, indicates
that HF diets indeed cause increased body fat accretion in comparison with consumption
ofequivalent energy from primarily carbohydrate. IfHF animals simply grew larger than
LF animals in this study, we could not draw the same conclusion.
That rats receiving both treatments displayed a failure to return to fasting blood
glucose (BG) concentrations by 2 h post-load following the 2 g/ BWkgoral glucose
challenge is interesting. Others (27) reported that in adult male Wistar rats consuming
either 11 % or 45% of calories from fat, the HF animals displayed a failure to return to
fasting BG within 2 h. It may be that 22% of calories from fat is greater than is easily
tolerated by this strain of rat, or that in female rats, the insulin resistance during puberty,
observed in humans (28), lasts beyond 13 weeks of age. Another possible explanation for
the sustained elevation in BG concentrations is that rats were fasted overnight before the
OGTTs. Because the room the animals were housed in was not ona reverse light-dark
cycle, the rats were fasted during their active cycle.
Mid-pubertal insulin resistance may also account for the increased insulin
secretion at all time points of the secondOGTT over the fITst and third OGTTs for both
the HF and LF groups. A post-adolescent recovery of insulin sensitivity could also
account for the overall decrease in insulin secretion at the third OGTT to evels similar to
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those seen at the first OGTT, when animals were 56 days old, the onset ofsexual
maturity in rats.
Researchers have shown that leptin responds to energy intake by initially
declining slightly, if at all, then increasing steadily between the first postprandial hour
and several hours postprandially (29;30). With the exception of the HF group at the first
OGTT, this same pattern is evident in both treatment groups at each OGTT. It is notable,
however, that leptin concentrations significantly increased over fasting in HF but not LF
rats at each OGTT, evidenced by the significant difference between groups in leptin
concentrations at each 2-h post-load time point. The lack of leptin rise in a lean versus an
obese subject.was also noticed by Chapelot and colleagues (29). This may be attributed to
hypersecretion of insulin by HF rats, as leptin has been shown to be released in response
to insulin both in vitro and in vivo (31). Levy and colleagues (32) observed that in male
SD rats, increases in serum leptin concentrations were not different between HF and LF
rat groups following an intravenous infusion of glucose or an 8 g chow meal at three
hours after administration. The difference between our findings and these may be due to
age, body composition, and gender differences between animals in each study.
Observed mean GH levels in this study are consistent with the literature.
Tannenbaum, et ale sampled GH every 15 min over 6 h, and found no difference between
HF and LF rats (9). Similarities between the HF and LF rats may be due to the relatively
small number of samples (n = 5 to 14 samples per time point) available for GH analysis.
Alternatively, because GH is secreted in pulses (20), a more frequent sampling schedule
may be needed to discern differences in temporal GH secretory patterns. In GH
concentrations may have been similar between groups because diet had no effect on GR.
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Another possibility is that animals in both groups were experiencing similar lean body
mass accretion. This also demonstrates the inability of GH to promote lipolysis and
suppress fat accretion.
A lack of difference in mean GH levels indicates that the increased insulin
resistanc'e in the HF group cannot be ascribed to differences in GH secretion. Instead, the
present data indicates that increased leptin secretion may precipitate increased insulin
resistance. In support of the latter suggestion, we observed significant positive
correlations between plasma insulin and leptin concentrations. The precise mechanism by
which leptin induces insulin resistance remains to be elucidated.
In conclusion, rats fed HF diets had significantly greater body mass, body fat
mass and percent body fat, and these changes were associated with increased serum leptin
concentrations. Lean body mass was not different between groups, nor were blood
glucose or serum GH concentrations. High-fat diet significantly increased serum insulin
and leptin concentrations in response to oral glucose tolerance tests. Results of this study
demonstrate that leptin but not GH is involved in the development of insulin resistance in
growing rats as a result of excess energy intake from dietary fat.
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Table 1. Composition and energy value of experimental diets.
Low-fat diet High-fat diet
g/kg Diet
Casein 200 200
Cornstarch 100 100
Sucrose 500 400
Cellulose 50 50
Soybean oil 100 200
Mineral mix* 35 39.3
Vitamin mixt 10 11.2
L-Cysteine 3 3
Choline Bitartrate 2 2
%kcal
CHO 58 43
Fat 22 39
Protein 20 17
kcal/ g diet
Energy Density 4.10 4.57
* Mineral mix composition, g/ kg mix: CaC03, 357; KH2P04, 196; K 3C6Hs0 7-H20,
70.78; Nael, 74; K2S04, 46.6; MgO, 24: FeCI2-6H20, 3.6; ZnC03, 1.65; MnC03, 0.63;
CuC03, 0.3; KI03, 0.01; Na2Se04, 0.01; NH4Mo04·H20, 0.008; Na2Si02, 1.45; LiCI2,
0.017; H3B03, 0.08; NaF, 0.064; NiC03, 0.032;~V03, .0066.
t Vitamin mix was obtained from Teklad, Madison, WI, catalog #40060.
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Table 2. Body mass analyses and food intake of rats fed high-fat and low-fat diets at 6, 8,
and 10 weeks of diet treatment. Values given are mean ± SEM for body composition
data, mean ± SD for food intake.
HF 6 weeks LF
Rats per group n=10 n=10
% Body Fat 13.2 ± 0.7 9.3 ± 0.7*
Body Fat, g 25.6 ± 1.5 17.1±1.5*
Lean Body Mass, g 161.5 ± 3.1 162.2±3.1
Food Intake, kcal/ day 57.0 ± 1.5 56.5 ± 4.6
8 weeks
Rats per group n=9 n=10
% Body Fat 13.0 ± 0.5 9.0 ± 0.5t
Body Fat, g 28.3 ± 1.3 18.9 ± 1.3t
Lean Body Mass, g 183.5 ± 3.5 183.0 ± 3.5
Food Intake, kcal/ day 52.2 ± 2.0 57.3 ± 2.8
10 weeks
Rats per group n=8 n=8
% Body Fat 13.1 ± 0.5 8.7 ± 0.5t
Body Fat, g 30.1 ± 1.4 19.0 ± 1.5t
Lean Body Mass, g 192.2 ± 3.8 193.6 ± 4.0
Food Intake, kcal/ day 56.5 ± 8.0 51.6 ± 3.3
*p < .0005, tP < .0001 for significance between groups.
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Table 3. Pearson correlation coefficients among fasting bl<:>od parameters, body weight,
and body fat percent in rats fed low-fat or high-fat diets.
Body DXA#l DXA#2 DXA#3 Fasting
Weight Body Fat Body Fat % Body Fat % Leptin
%
OGTT#l
Insulin 0.59* O.60t 0.75t
Leptin 0.51 * O.71t
Body weight 0.35 0.51 *
OGTT#2
Insulin 0.55* 0.59* 0.57* 0.33
Leptin -0.02 0.18 0.24
Body weight O.42t 0.48* -0.02
OGTT#3
Insulin O.76t O.74t 0.86t 0.68t
Leptin 0.53* 0.50* 0.61 *
Body weight 0.46* 0.53* 0.53*
*p < .05, tp < .001 for significance of relationship between variables, tTendency for
sigtiificance, p < .10. (n = 15 to 20)
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Figure 1. Baseline and weekly body weights of female rats fed low-fat (LF) or high-fat
(HF) diets. *p < .05 significant difference ofbody weight between groups; n = 9 to 10
rats per group.
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Figure 2. Percentage ofbody fat in female rats fed low-fat (LF) or high-fat (HF)diets
after 6,8, and 10 weeks of diet treatment, as measured by Dua' X-ray Absorptiometry
(DXA) analysis. *p < .0001 for difference between LF and HF groups; n=8 to 10 rats per
group.
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Figure 3. Lean body mass of female rats fed low-fat (LF) or high-fat (HF) diets after 6,8,
and 10 weeks of diet treatment, as determined by Dual X-ray Absorptiometry (DXA)
analysis; n ~ 9 to 10 rats per group.
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Figure 4. Blood glucose concentrations of rats fed low-fat or high-fat diets at fasting
(0 min) and in response to a 2 g/ BWkg oral glucose challenge following 5, 7, and 9 weeks
ofdiet treatment; n = 8 to 10 rats per group per time point.
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Figure 5. Serum insulin concentrations of rats fed low-fat (LF) or high-fat (HF) diets at
fasting (0 min) and in response to a 2 g/ BWkg oral glucose challenge following 5, 7,
and 9 weeks of diet treatment; n = 8 to 10 rats per group per time point.
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Figure 6. Serum leptin concentrations of rats fed low-fat (LF) or high-fat diets (HF) at
fasting (0 min) and in response to a 2 g/ BWkg oral glucose challenge following 5, 7, and
9 weeks of diet treatment; n = 8 to 10 rats per group per time point.
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CHAPTER V
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Summary
This study was designed to examine the effects ofHF diet on body composition
and leptin, insulin, and GH responses to OGTTs. Twenty female weanling SD rats were
randomly assigned to receive either a HF (39% kcals from fat) or LF (22% keals from
fat) diet upon arrival. Animals were provided excess food energy in comparison to their
calculated requirements, and animals in each group were given the same number ofkcal
daily (53 ± 0.5 kcal the first 2 weeks, 65 ± 0.5 kcal for the remainder of the study). Oral
glucose tolerance tests were perfonned after 5, 7, and 9 weeks of diet treatment. Animals
received a 50% glucose solution (2 g/ BWkg) via gavage glucose following an overnight
fast. Blood was sampled at fasting and at 30, 60, and 120 min after the glucose load for
measurement ofBG and serum insulin, leptin, and GH. Body mass analysis was
conducted by DXA under ketaminel xylazine sedation after 6, 8, and 10 weeks of diet
treatment.
HF diet induced greater body weight gain and body fat accretion, which were
observed after 6 weeks of diet treatment. Insulin"resistance was evidenced by
significantly greater insulin AUes in the HF rats compared to the LF rats at OGTT 1 and
OGTT 2, as well as increased fasting insulin concentrat·ons at OGTT 2. Leptin secretion
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was greater in HF rats during all OGTTs compared to the LF rats, although fasting levels
of leptin were not different between groups. GH concentrations were not different
between groups at any time point, which indicates that diet did not influence GH
secretion, and that rats in both groups had similar GH secretion.
Conclusions
In order to test the following hypotheses, the objectives of this study were to
detennine the effects of dietary fat content on growth (weight gain) and adiposity (%
body fat) in rats isocalorically fed diets that have high or low fat content and to detennine
the effects of dietary fat content on glucose, insulin, leptin and growth hormone
responses to oral glucose tolerance tests over time. Each hypothesis is addressed below.
HI Rats fed HF diets will have greater total body mass and body fat content
compared to rats isocalorically fed LF diets.
In this study, rats fed HF diets developed greater body mass (p < .05) compared to
LF rats, which was evident after 7 weeks of diet treatment. Body fat content, expressed as
a percentage ofbody mass, was greater in HF rats than LF rats after 6 weeks of diet
treatment (p < .005).
H2 Rats fed HF diets will produce significantly higher leptin responses to oral
glucose tolerance challenges compared to rats isocalorically fed LF diets during growth.
Although fasting leptin concentrations were not significantly different between
groups, HF rats had significantly greater serum leptin concentrations 2 h after oral
glucose administration (p < .0001) compared to fasting while LF rats did not exhibit
significant increases in leptin concentrations compared to fasting. 2-hour leptin
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concentrations were significantly greater in HF rats compared to LF rats at all OGTTs
(p < .05 to P < .0001).
H3 Rats fed high-fat diets will develop insulin resistance, evidenced by amplified
insulin responses to oral glucose tolerance tests, compared to isocalorically low-fat fed
rats.
In maintaining similar BG concentrations at all OGTTs, HF rats had greater
insulin concentrations at fasting during OGTT 2 and 3 (p < .05), and in response to
OGTT 1 and 2 (p < .05). This demonstrated that HF rats required more endogenous
insulin to promote glucose uptake by the tissues.
~ GH concentrations of rats fed high-fat diets will not be different from growth
honnone concentrations of rats isocalorically fed low-fat diets.
GH concentrations were not different between HF and LF rats at any point during
the OGTTs.
As a result of this study, it is hypothesized that HF diets induce insulin resistance
through the effects ofleptin's action on or involvement in a variety of pathways, such as:
• Inducing insulin resistance at the peripheral tissues through its effect on insulin
receptors or post-receptor antagonism of the insulin signaling pathway,
• In obesity, the ratio of freely circulating leptin to that bound to carrier proteins in
the blood is altered,
• Its relationship to the production ofproteins such as protein tyrosine-phosphatase
IB (PTP-1B), ghrelin, or resistin, which are newly discovered molecules involved
in insulin resistance or satiety,
• Its relationship to cytokine production or other honnones such as glucocorticoids.
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Recommendations
This study was designed to evaluate the effects of high-fat feeding during rapid
growth in female rats. Due to limited resources, we were not able to examine rats
younger than 56 days of age. Ideally, a larger, longitudinal study using more rats, and rats
ofboth genders, would allow examination of the effects of chronic HF diet on body
composition and hormonal changes resulting from diet treatment both earlier and later in
treatment duration. A study such as this may also offer insight into whether the body
composition and hormonal variations we have seen occur in both genders at the same
age. It would also provide an opportunity to examine the effects of life-long HF diet
consumption and resultant body composition alterations on all of the parameters
examined herein. Such a study conducted' in another rat species, such as Fisher 344 or
Wistar rats, may provide further insight into the development of diet-induced obesity and!
or diabetes.
In this study, although equal amounts of vitamins and minerals were provided per
kcal, protein and fiber content were not adjusted per kcal. This difference in treatments
may have had some unknown effect on the' outcome of the study, but the difference in
protein and fiber per kcal were very small. To exclude the possibility of these differences
affecting study outcomes, future research diets should be adjusted to provide equal
amounts ofdietary components per kcal, so that fat is the only dietary variable.
Leptin serves as a feedback inhibitor on insulin secretion in both humans and
rodents. One other limitation of this animal study is that rodents do not develop leptin
resistance as observed i~ humans. Research into the cellular mechanism of leptin
resistance in humans is called for to elucidate the exact role leptin plays in dietary fat-
induced insulin resistance. Possible methods for examining the cellular mechanism of
leptin at the cellular level include microarray and RT peR studies on both muscle and
adipose tissue ofanimals to determine leptin's relationship to gene expression of
potential molecules involved in cellular insulin resistance.
Longitudinal studies should be conducted to determine iftype 2 DM can be
induced by chronic HF feeding. As has been observed in humans, type 2 DM develops
from insulin resistance when preventive interventions are not implemented.
Well-controlled dietary studies in humans are few and difficult to conduct.
Ideally, a well-controlled feeding study in human subjects for an extended period of time
would be in order to examine the changes in body composition and the plethora of
honnones related to insulin sensitivity and the body's ability to maintain nonnal glucose
homeostasis.
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Studies examining the effects of high-fat diets in rodents.
Author, year HF diet % fat! source Strain! gender/ weight or N Duration of diet treatment Method of evaluation! glucose
age dose
Wilkes, 1998 60% kcal/ safflower oil SD/ male/ 200g 45 3 weeks Intravenous glucose tolerance
test (IVGTT)/ 300 mg.BWkg
Pawlak, 2001 60% kcal/? Albino Wistar/?/ 215 g ? 4 weeks IVGTT/l g/ BWkg,
hyperinsulinemic euglycemic
clamp
Commerford, 2000 45% weight! ? Crl(WI)BRI male/ 7 weeks 92 5 weeks Fasting blood parameters
Fryer, 1993 550/0 kcal/ lard Ludwig Wistar/ ?/ 80-100 g 24 6 weeks OGTT/ 400 mg/ BWkg
Buettner, .2000 45% kcal/ safflower oil Wistar/ male/ 150-175 g 8 6 weeks OGTT/2 g/BWg
Kim, 2000 50% kcaV lard & com Wistar/ male/ weanling 60 4 weeks Muscle incubation, 2-DG
oil uptake
Steinberg, 2000 60% kcal/ safflower oil SD/ female/ 165 g ? 4 weeks Muscle pulse-chase clamp
study
Storlien, 1991 59% kcaV varying Wistar/ male/ 280 g, 54 ? 30 days Hyperinsulinemic euglycemic
00
sources days clauip\0
Ahren, 1997 58% kcaV? C57BL/6J ( mice)/ female/ ? 1,2, 6, 10 months Non-fasting blood parameters
4 weeks
Wang, 1998 Choice diet paradigm! ? SD/?/ ? ? 4-5 weeks Non-fasting blood parameters
Oakes, 1997 59°A> kcals/ ? Wistar/ male/ 250 g ? 3 weeks IIyperinsulinemic euglycemic
clamp
Kraegen, 1991 59% kcals/ safflower oil Wistar/ male/ 300-380 g ? 3 days & 3 weeks IVGTT, 500 nlg1 BWkg /
Hyperinsulinemic euglycemic
clamp
LevY,2000 24% weight!? SD& Fischer 344/ male/ 2 ? 6 weeks IV Glucose infusion, 6.8 g/
months BWkg
Storlien, 1986 59% kcaV safflower oil Wistar/ male/ 300g 29 3 days & 3 weeks Mid-physiologic euglycemic
20A
clamp
Tannenbaum, 1997 20% weight! com oil Long-Evans/ male/ Adult 5 days, 1 week, 3 weeks, 9 A non-fasting blood
178 weeks, 12 weeks ~arameters
Insulin tolerance test, 0.125
mUfBWkg
York, 2001 56% kcall? Osborn-Mendell male/ 12 50 80 days Non-fasting blood parameters
weeks
Author, year HF diet % fat! source Strain! gender/ weight or N Duration of diet treatment Method of evaluation! glucose
age dose
Kim, 2000 66.50/0 kcall shortening SD/ male/? 36 3 weeks Hyperinsulinemic euglycemic
& com oil clamp
Mooradian, 2000 90.70/0 kcall ? Fischer 344/ ?/ 3 month 50 10 days Non-fasting blood parameters
Ahren, 1998 580/0 kcal/ ? C57BL/6J mice/ female/ 4 6SA 1.5 years A Intraperitoneal glucose
weeks 1638 tolerance test
B Non-fasting blood
parameters
Ainslie, 2000 36% keals/? Hooded Wistar/ female/ 70 4 weeks Non-fasting blood parameters
20-22 weeks
Wilkes JJ, Bonen A, Bell RC: A modified high-fat diet induces insulin resistance in rat skeletal muscle but not adipocytes. American Journal ofPhysiology,
Endocrinology and Metabolism 275:E679-E686, 1998
Pawlak DB, Bryson JM, Denyer GS, Brand-Miller JC: High glycemic index starch promotes hypersecretion of insulin and higher body fat in rats withoUT affectin
~ insulin sensitivity. The Journal ofNutrition 131 :99-104, 2001
Commerford SR, Pagliassotti MJ, Melby CL, Wei Y, Gayles Ee, Hill JO: Fat oxidation, lipolysis, and free fatty acid recycling in obesity-prone and obesity-
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0SU Institutional Animal (ore ond Use CommitteeStillwafer, Oklahoma 74078~05·744-7631
~-
September 18, 2000
Institutional Animal Care and Use Committee Action
This protocol was reviewed by the IACUC with the following action:
Principle Investigator: Dr. Maria Spicer
Department: Nutritional Sciences
Protocol Title: Effects of Chromium and sucrsose feeding on metabolic honnones
and subsrate utilization
Protocol Number: HE~Ol-16
Animal Number and Species: 80 Rats
Expiration Date: 9-30-03
Approval XX----._Deferral_---.:.. _
Approval Vlith Modifications _
Comments:
Date of final Institutional Committee Action .;;...9-...;.7..-;-O;..;O~__
Signature ofIACUC Chairman ---=:J-~~~~:::::_~"":"--===-=
Signature ofIACUC VeterinariaIi---J...~~~~~-...c..~~~~'-Date --r-~~..,s--::.---."
Institutional Assurance Number A3722-01
For Committee Administrative Purposes OnJy
Additional infonnation was requested and has been provided by P.I.
__ Significant modifications to ACUF were requested (see attached information).
-I".'I .,, .
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COMPOSITION OF MINERAL MIX, gI kg:
Calcium carbonate, anhydrous, 40.04% Ca 357
Potassium phosphate, monobasic, 22.76%P, 28.73% K 196
Potassium citrate, tri-potassium, monohydrate, 36.16% K 70.78
Sodium chloride, 39.34% Na, 60.66% CI 74
Potassium sulfate, 44.87% K, 18.39% S 46.60
Magnesium oxide, 60.32% Mg 24
Iron(II) chloride, 28.1 % Fe 3.60
Zinc carbonate, 52.14% Zn 1.65
Manganous carbonate, 47.790/0 Mn 0.63
Cupric carbonate, 57.47%Cu 0.30
Potassium iodate, 59.3% I 0.01
Sodium selenate, 41.79% Se 1.0
Ammonium paramolybdate, 4 hydrate, 54.34% Mo 1.0
Sodium metasilicate, anhydrous 0.6228
Lithium chloride, 16.38% Li 0.017
Boric acid, 17.5%B 0.082
Sodium fluoride, 45.240/0 F 0.064
Nickel carbonate, 45% Ni 0.032
Ammonium 43.55% V 0.0066
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20 Variables: ratid
gluc60
totg
trmt
gluc120
pctfat
lepO
insO
lep30
ins30
lep60
ins60
lep120
ins120
weight
bmcg
glueO
fatg
gluc30
leang
Simple Statistics
Variable N Mean Std Dev Sum Minimum Maximum
ratid 20 15.00000 8.85557 300.00000 1.00000 29.00000
trmt 20 1.50000 0.51299 30.00000 1.00000 2.00000
lepO 16 1.81652 1.00892 29.06427 0.83401 5.03060
lap30 12 1.90897 0.63564 22.90767 0.66745 3.00810
lep60 13 1.64105 0.41723 21.33370 0.79100 2.33250
lep120 16 2.15923 0.80348 34.54760 1.38430 4.12200
weight 20 165.25800 11.07731 3305 137.41000 185.47000
glueO 19 95.84211 15.69240 1821 62.00000 137.00000
gluc30 20 202.95000 25.09660 4059 154.00000 239.00000
gluc60 19 214.89474 31 .30476 4083 169.00000 269.00000
gluc120 20 190.80000 45.74368 3816 134.00,000 282.00000
insO 20 0.55117 0.39028 11.02333 0.10000 2.00170
ins30 20 1.50125 0.63779 30.02490 0.61818 3.11200
ins60 19 1.49938 0.52225 28.48820 0.97515 2.94850
ins120 17 1.16808 0.39954 19.85731 0.47158 1.95910
bmcg 20 5.23500 0.42212 104.70000 4.20000 6.00000
fatg 20 21.33000 6.39392 426.60000 12.60000 41.10000
leang 20 161.84500 9.48359 3237 142.30000 175.70000
totg 20 188.41000 12.03621 3768 160.90000 209.50000
pettat 20 11.24000 2.89689 224.80000 6.70000 19.70000
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid trmt lepO lep30 lep60 lep120 weight
ratid 1.00000 0.05793 0.23885 ·0.06448 ·0.07229 0.15485 0.13048
0.8083 0.3730 0.8422 0.8145 0.5669 0.5835
20 20 16 12 13 16 20
trmt 0.05793 1.00000 0.40077 0.68722 0.38946 0.66514 0.34992
0.8083 0.1240 0.0135 0.1884 0.0049 0.1304
20 20 16 12 13 16 20
lepO 0.23885 0.40077 1.00000 0.75343 0.33281 0.74330 0.51321
0.3730 0.1240 0.0074 0.2905 0.0023 6.0420
16 16 16 11 12 14 16
97
Correlations Among Variables
OGTT 1 to DXA 1
The SAS System 15:03 Thursday, May 9, 2002 29
The CORR Procedure
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Numper of Observations
ratid trmt lepO lep30 lep60 lep120 weight
lep30
-0.06448 0.68722 0.75343 1 .00000 0.88790 0.78564 0.75461
0.8422 0.0135 0.0074 0.0032 0.0025 0.0046
12 12 11 12 8 12 12
lep60
-0.07229 0.38946 0.33281 0.88790 1.00000 0.73354 0.43680
0.8145 0.1884 0.2905 0.0032 0.0066 0.1356
13 13 12 8 13 12 13
lep120 0.15485 0.66514 0.74330 0.78564 0.73354 1 .00000 0.44159
0.5669 0.0049 0.0023 0.0025 0.0066 0.0868
16 16 14 12 12 16 16
weight 0.13048 0.34992 0.51321 0.75461 0.43680 0.44159 1.00000
0.5835 0.1304 0.0420 0.0046 0.1356 0.0868
20 20 16 12 13 16 20
glueO -0.40550 -0.10751 0.46220 0.33778 -0.17242 0.11029 0.03163
0.0850 0.6613 0.0828 0.2829 0.5921 0.6956 0.8977
19 19 15 12 12 15 19
gluc30 -0.06986 -0.16966 -0.32883 0.08744 0.55832 -0.16878 0.10932
0.7698 0.4746 0.2137 0.7870 0.0474 0.5321 0.6464
20 20 16 12 13 16 20
gluc60 0.08443 0.04479 -0.01529 0.68478 0.54269 0.08056 0.40802
0.7311 0.8555 0.9569 0.0140 0.0553 0.7668 0.0829
19 19 15 12 13 16 19
gluc120 0.09394 -0.04037 -0.21411 -0.03931 0.35885 0.06468 0.11052
0.6936 0.8658 0.4259 0.9035 0.2285 0.8119 0.6428
20 20 16 12 13 16 20
insO -0.17486 0.21874 0.74770 0.67041 0.44296 0.54181 0.58521
0.4609 0.3542 0.0009 0.0170 0.1295 0.0302 0.0067
20 20 16 12 13 16 20
ins30 0.12726 0.45720 0.48286 0.68978 0.46788 0.57678 0.47379
0.5929 0.0427 0.0582 0.0131 0.1069 0.0193 0.0348
20 20 16 12 13 16 20
ins60 0.45885 0.08892 0.39393 0.44352 0.30571 0.50287 0:29858
0.0481 0.7174 0.1463 0.1487 0.3097 0.0471 0.2144
19 19 15 12 13 16 19
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Numper of Observations
ratid trmt lepO lep30 lep60 lep120 weight
ins120 0.22369 0.45289 0.77775 0.54228 -0.00558 0.55486 0.53457
0.3881 0.0679 0.0017 0.0848 0.9870 0.0395 0.0271
17 17 13 11 11 14 17
bmcg
-0.26892 0.27951 0.38137 0.53657 0.25642 0.20644- 0.77272
0.2516 0.2327 0.1450 0.0721 0.3978 0.4430 <.0001
20 20 16 12 13 16 20
fatg
-0.12865 0.68678 0.72599 0.75337 0.20773 0.68455 0.51530
0.5888 0.0008 0.0015 0.0047 0.4959 0.0034 0.0201
20 20 16 12 13 16 20
leang
-0.07796 -0.03624 -0.00487 0.38098 0.34164 -0.05020 0.80153
0.7439 0.8794 0.9857 0.2218 0.2533 0.8535 <.0001
20 20 16 12 13 16 20
totg -0.13861 0.34608 0.38370 0.68766 0.35437 0.30367 0.93254
0.5600 0.1350 0.1423 0.0135 0.2348 0.2529 <.0001
20 20 16 12 13 16 20
pctfat -0.11530 0.69770 0.71323 0.70371 0.11317 0.71160 0.34644
0.6283 0.0006 0.0019 0.0106 0.7128 0.0020 0.1346
20 20 16 12 13 16 20
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
glucO gluc30 gluc60 gluc120 insO ins30 ins60
ratid -0.40550 -0.06986 0.08443 0.09394 -0.17486 0.12726 0.45885
0.0850 0.7698 0.7311 0.6936 0.4609 0.5929 0.0481
19 20 19 20 20 20 19
trmt -0.10751 -0.16966 0.04479 -0.04037 0.21814 0.45720 0.08892
0.6613 0.4746 0.8555 0.8658 0.3542 0.0427 0.7174
19 20 19 20 20 20 19
lepO 0.46220 -0.32883 -0.01529 -0.21411 0.74770 0.48286 0.39393
0.0828 0.2137 0.9569 0.4259 0.0009 0.0582 0.1463
15 16 15 16 16 16 15
lep30 0.33778 0.08744 0.68478 -0.03931 0.67041 0.68978 0.44352
0.2829 0.7870 0.0140 0.9035 0.0170 0.0131 0.1487
12 12 12 12 12 12 12
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
glueO glue30 gluc60 gluc120 insO 1ns30 1ns60
lep60 ·0.17242 0.55832 0.54269 0.35885 0.44296 0.46788 0.30571
0.5921 0.0474 0.0553 0.2285 0.1295 0.1069 0.3097
12 13 13 13 13 13 13
lep120 0.11029 ·0.16878 0.08056 0.06468 0.54181 0.57678 0.50287
0.6956 0.5321 0.7668 0.8119 0.0302 0.0193 0.0471
15 16 16 16 16 16 16
weight 0.03163 0.10932 0.40802 0.11052 0.58521 0.47379 0.29858
0.8977 0.6464 0.0829 0.6428 0.0067 0.0348 0.2144
19 20 19 20 20 20 19
glueO 1.00000 ~0.29072 0.10182 ~0.23941 0.62901 0.25395 0.03045
0.2273 0.6877 0.3235 0.0039 0.2941 0.9045
19 19 18 19 19 19 18
gluc30 ·0.29072 1 •noooo 0.57483 0.49150 -0.24817 0.19009 0.33489
0.2273 0.0100 0.0277 0.2914 0.4221 O. 1611
19 20 19 20 20 20 19
gluc60 0.10182 0.57483 1.00000 0.53478 0.11246 0.27887 0.43926
0.6877 0.0100 0.0183 0.6467 0.2476 0.0599
18 19 19 19 19 19 19
gluc120 -0.23941 0.49150 0.53478 1.00000 -0.08856 0.14779 0.16666
0.3235 0.0277 0.0183 0.7104 0.5341 0.4953
19 20 19 20 20 20 19
insO 0.62901 ·0.24817 0.11246 -0.08856 1.00000 0.38597 0.30025
0.0039 0.2914 0.6467 0.7104 0.0928 0.2117
19 20 19 20 20 20 19
ins30 0.25395 0.19009 0.27887 0.14779 0.38597 1.00000 0.32084
0.2941 0.4221 0.2476 0.5341 0.0928 0.1805
19 20 19 20 20 20 19
ins60 0.03045 0.33489 0.43926 0.16666 0.30025 0.32084 1.00000
0.9045 O. f611 0.0599 0.4953 0.2117 0.1805
18 19 19 19 19 19 19
ins120 0.01457 -0.12038 0.05208 0.25570 0.53420 0.42625 O.~6734
0.9557 0.6454 0.8426 0.3219 0.0272 0.0880 0.0586
17 17 17 17 17 17 11
100
Correlations Among Variables
OGTT 1 to DXA 1
The SAS System
The CORR Procedure
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
15:03 Thursday, May 9, 2002 32
bmcg
fatg
leang
totg
petfat
glucO
0.09389
0.7022
19
0.26960
0.2643
19
-0.09676
0.6935
19
0.07662
0.7552
19
0.24588
0.3102
19
gluc30
0.00961
0.9679
20
-0.36964
0.1087
20
0.26376
0.2612
20
0.01246
0.9584
20
-0.39560
0.0843
20
gluc60
0.01995
0.9354
19
-0.19826
0.4158
19
0.49671
0.0305
19
0.28188
0.2423
19
-0.29856
0.2144
19
gluc120
-0.12827
0.5899
20
-0.27237
0.2453
20
0.18595
0.4325
20
0.00026
0.9991
20
-0.30834
0.1859
20
insO
0.52184
0.0183
20
0.69446
0.0007
20
0.29328
0.2095
20
0.61810
0.0037
20
0.60204
0.0050
20
ins30
0.28677
0.2203
20
0.43587
0.0547
20
0.10043
0.6736
20
0.32004
0.1689
20
0.41026
0.0724
20
ins60
·0.10138
0.6796
19
0.03795
0.8774
19
0.10697
0.6629
19
0.10008
0.6835
19
0.00341
0.9889
19
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid
trmt
lepO
lep30
lepSO
ins120
0.22369
0.3881
17
0.45289
0.0679
17
0.77775
0.0017
13
0.54228
0.0848
11
-0.00558
0.9870
11
bmcg
-0.26892
0.2516
20
0.27951
0.2327
20
0.38137
0.1450
16
0.53657
0.0721
12
0.25642
0.3978
13
fatg
-0.12865
0.5888
20
0.68678
0.0008
20
0.72599
0.0015
16
0.75337
0.0047
12
0.20773
0.4959
13
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leang
-0.07796
0.7439
20
-0.03624
0.8794
20
-0.00487
0.9857
16
0.38098
0.2218
12
0.34164
0.2533
13
totg
-0.13861
0.5600
20
0.34608
0.1350
20
0.38370
0.1423
16
0.68766
0.0135
12
0.35437
0.2348
13
pctfat
-0.11530
0.6283
20
0.69770
0.0006
20
0.71323
0.0019
16
0.70317
0.0106
1"2
0.11317
0.7128
13
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ins120 bmcg fatg leang totg pctfat
lep120 0.55486 0.20644 0.68455 -0.05020 0.30367 0.11160
0.0395 0.4430 0.0034 0.8535 0.2529 0.0020
14 16 16 16 16 16
weight 0.53457 0.77272 0.51530 0.80153 0.93254 0.34644
0.0271 <.0001 0.0201 <.0001 <.0001 0.1346
17 20 20 ·20 20 20
glucO 0.01457 0.09389 0.26960 -0.09676 0.07662 0.24588
0.9557 0.7022 0.2643 0.6935 0.7552 0.3102
17 19 19 19 19 19
gluc30 -0.12038 0.00961 -0.36964 0.26376 0.01246 -0.39560
0.6454 0.9679 0.1087 0.2612 0.9584 0.0843
17 20 20 20 20 20
gluc60 0.05208 0.01995 -0.19826 0.49671 0.28188 -0.29856
0.8426 0.9354 0.4158 0.0305 0.2423 0.2144
17 19 19 19 19 19
g!uc120 0.25570 -0.12827 -0.27237 0.18595 0.00026 -0.30834
0.3219 0.5899 0.2.453 0.4325 0.9991 0.1859
17 20 20 20 20 20
insO 0.53420 0.52184 0.69446 0.29328 0.61810 0.60204
0.0272 0.0183 0.0007 0.2095 0.0037 0.0050
17 20 20 20 20 20
ins30 0.42625 0.28677 0.43587 0.10043 0.32004 0.41026
0.0880 0.2203 0.0547 0.6736 0.1689 0.0724
17 20 20 20 20 20
ins60 0.46734 -0.10138 0.03795 0.10697 0.10008
0.00341
0.0586 0.6796 0.8774 0.6629 0.6835 0.9889
17 19 19 19 19 19
ins120 1.00000 0.34273 0.54080 0.09349
0.45254 0.49842
0.1781 0.0250 0.7212 0.0682 0.0417
17 17 17 17 17 17
bmcg 0.34273 1.00000 0.61073 0.66826
0.88563 0.48429
0.1781 0.0042 0.0013 <.0001 0.0305
17 20 20 20 20
20
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Pearson Correlation Coefficients
Prob> Irl under HO: Rho=O
Number of Observations
ins120 bmcg fatg leang totg pctfat
fatg 0.54080 0.61073 1 .00000 0.04343 0.58613 0.97874
0.0250 . 0.0042 0.8557 0.0066 <.0001
17 20 20 20 20 20
leang 0.09349 0.66826 .0.04343 1.00000 0.83474 -0.15398
0.7212 0.0013 ~.8557 <.0001 0.5169
17 20 20 20 20 20
totg 0.45254 0.88563 0.58613 0.83474 1.00000 0.41477
0.0682 <.0001 0.0066 <.0001 0.0690
17 20 20 20 20 20
pctfat 0.49842 0.48429 0.97874 -0.15398 0.41477 1.00000
0.0417 0.0305 <.0001 0.5169 0.0690
17 20 20 20 20 20
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20 Variables: ratid trmt lepO lep30 lep60 lep120 weight glueO glue30
gluc60 gluc120 insO ins30 ins60 ins120 bmcg fatg leang
totg pctfat
Simple Statistics
Variable N Mean Std Dev Sum Minimum Maximum
ratid 20 15.00000 8.85557 300.00000 1.00000 29.00000
trmt 20 1.50000 0.51299 30.00000 1.00000 2.00000
lepO 15 1 .43786 0.45223 21.56789 0.80641 2.69970
lep30 12 1.34815 0.36963 16.17775 0.92064 1 .98810
lep60 18 1.63558 0.52130 29.44043 0.84110 2.78460
lep120 16 2.11033 0.77930 33.76526 0.97476 4.01190
weight 20 190.94600 12.41382 3819 156.28000 209.53000
glueO 20 102.25000 8.16201 2045 79.00000 115.00000
gluc30 19 189.89474 21.23125 3608 148.00000 237.00000
gluc60 19 206.21053 36.89411 3918 124.00000 301.00000
gluc120 19 165.10526 32.19713 3137 106.00000 228.00000
insO 19 1.57057 0.63813 29.84078 0.37882 2.66280
ins30 19 2.29511 0.70842 43.60709 0.81409 3.55390
ins60 19 2.09443 0.55522 39.79410 1.15240 2.98650
ins120 19 1 .89972 0.56284 36.09470 0.73220 2.77420
bmeg 20 6.05500 0.46394 121.10000 4.90000 6.90000
fatg 20 23.59500 6.20683 471.9000"0 16.20000 35.00000
leang 20 183.25500 10.89517 3665 153.70000 197.30000
totg 20 212.89000 14.26217 4258 174.80000 236.20000
petfat 20 11.00500 2.46544 220.10000 7.50000 15.60000
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid
trmt
lepO
ratid trmt lepO lep30 lap60 lep120 weight
1.00000 0.05793 -0.12406 0.08195 -0.08959 0.09519 0.01573
0.8083 0.6596 0.8001 0.7237 0.7258 0.9475
20 20 15 12 18 16 20
0.05793 1.00000 0.16252 0.53164 0.48507 0.56278 0.44233
0.8083 0.5628 0.0753 0.0413 0.0232 0.0508
20 20 15 12 18 16 20
-0.12406 0.16252 1.00000 0.67920 0.60980 0.81873 -0.02597
0.6596 0.5628 0.0308 0.0158 0.0003 0.9268
15 15 15 10 15 14 15
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Numper of Observations
ratid trmt lepO lep30 lep60 lep120 weight
lep30 0.08195 0.53164 0.67920 1.00000 0.91083 0.88457 0.25726
0.8001 0.0753 0.0308 <.0001 0.0003 0.4195
12 12 10 12 12 11 12
lap60 -0.08959 0.48507 0.60980 0.91083 1.00000 0.89041 0.47613
0.7237 0.0413 0.0158 <.0001 <.0001 0.0458
18 18 15 12 18 16 18
lep120 0.09519 0.56278 0.81873 0.88457 0.89041 1.00000 0.37061
0.7258 0.0232 0.0003 0.0003 <.0001 0.1576
16 16 14 11 16 16 16
weight 0.01573 0.44233 -0.02597 0.25726 0.47613 0.37061 1.00000
0.9475 0.0508 0.9268 0.4195 0.0458 0.1576
20 20 15 12 18 16 20
glueO 0.35680 0.25769 0.12473 0.49369 0.30276 0.25059 0.18754
0.1225 0.2727 0.6578 0.1028 0.2220 0.3492 0.4285
20 20 15 12 18 16 20
glue30 0.04194 0.32162 0.02201 0.44224 0.32783 0.16708 0.24986
0.8647 0.1794 0.9379 0.1500 0.1841 0.5363 0.3022
19 19 15 12 18 16 19
gluC60 0.29132 0.63373 0.04126 0.42885 0.13008 0.26516 0.25681
0.2262 0.0036 0.8839 0.1642 0.6069 0.3209 0.2885
19 19 15 12 18 16 19
gluC120 0.40684 0.15455 0.12952 0.37288 0.07195 0.14882 -0.04044
0.0839 0.5276 0.6455 0.2326 0.7766 0.5823 0.8694
19 19 15 12 18 16 19
insO -0.12548 0.50094 0.32853 0.75372 0.85256 0.71266 0.54834
0.6087 0.0289 0.2319 0.0046 <.0001 0.0019 0.0151
19 19 15 12 18 16 19
ins30 -0.12850 0.21053 0.04845 0.30865 0.39978
0.20209 0.32708
0.6001 0.3870 0.8639 0.3290 0.1002 0.4529 0.1717
19 19 15 12 18 16 19
ins60 -0.03845 0.33177 0.05731 -0.02034
0.02158 -0.04608 0:'11665
0.8758 0.1652 0.8392 0.9500 0.9323 0.8654
0.6344
19 19 15 12 18 16
19
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid trmt lepO lep30 lep60 lep120 weight
ins120 -0.10391 0.43926
-0.09470 0.45430 0.08491 0.11413 0.08724
0.6721 0.0599 0.7371 0.1379 0.7376 0.6738 0.7225
19 19 15 12 18 16 19
bmcg -0.22291 0.23220 0.11395 -0.01666 0.32410 0.32185 0.86343
0.3448 0.3246 0.68~9· 0.9590 0.1895 0.2241 <.0001
20 20 15 12 18 f6 20
fatg -0.07287 0.78269 0.22876 0.45869 0.50810 0.58201 0.65484
0.7601 <.0001 0.4122 0.1337 0.0313 0.0180 0.0017
20 20 15 12 18 16 20
leang 0.02520 0.02401 -0.16418 0.03578 0.26982 0.15750 0.85945
0.9160 0.9200 0.5587 0.9121 0.2789 0.5602 <.0001
20 20 15 12 18 16 20
totg -0.02092 0.36616 -0.00543 0.24661 0.42529 0.36799 0.96925
0.9302 0.1123 0.9847 0.4397 0.0785 0.1608 <.0001
20 20 15 12 18 16 20
petfat -0.06485 0.80940 0.24497 0.45553 0.46714 0.57727 0.48342
0.7859 <.0001 0.3789 0.1367 0.0506 0.0192 0.0308
20 20 15 12 18 16 20
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
glueO gluc30 glue60 glue120 insO ins30 in560
ratid 0.35680 0.04194 0.29132 0.40684 -0.12548 -0.12850 -0.03845
0.1225 0.8647 0.2262 0.0839 0.6087 0.6001 0.8758
20 19 19 19 19 19 19
trmt 0.25769 0.32162 0.63373 0.15455 0.50094 0.21053 0.33177
0.2727 0.1794 0.0036 0.5276 0.0289 0.3870 0.1652
20 19 19 19 19 19 19
lepO 0.12473 0.02201 0.04126 0.12952 0.32853 0.04845 0.05731
0.6578 0.9379 0.8839 0.6455 0.2319 0.8639 0.8392
15 15 15 15 15 15 15
lep30 0.49369 0.44224 0.42885 0.37288 0.75372 0.30865 -0.02034
0.1028 0.1500 0.1642 0.2326 0.0046 0.3290 0.9500
12 12 12 12 12 12 12
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
glucO gluc30 gluc60 gluc120 insO ins30 ins60
lep60 0.30276 0.32783 0.13008 0.07195 0.85256 0.39978 0.02158
0.2220 0.1841 0.6069 0.7766 <.0001 0.1002 0.9323
18 18 18 18 18 18 18
lep120 0.25059 0.16708 0.26516 0.14882 0.71266 0.20209 -0.04608
0.3492 0.5363 0.3209 0.5823 0.0019 0.4529 0.8654
16 16 16 16 16 16 16
weight 0.18754 0.24986 0.25681 -0.04044 0.54834 0.32708 0.11665
0.4285 0.3022 0.2885 0.8694 0.0151 0.1717 0.6344
20 19 19 19 19 19 19
glueO 1.00000 0.33991 0.42245 0.43194 0.39161 -0.11586 0.23018
0.1544 0.0116 0.0648 0.0973 0.6367 0.3431
20 19 19 19 19 19 19
gluc30 0.33997 1.00000 0.53572 0.49374 0.36935 0.47724 0.24355
0.1544 0.0181 0.0317 0.1314 0.0388 0.3150
19 19 19 19 18 19 19
gluc60 0.42245 0.53572 1.00000 0.48637 0.17694 -0.03523 0.20447
0.0716 0.0181 0.0347 0.4824 0.8861 0.4011
19 19 19 19 18 19 19
glue120 0.43194 0.49374 0.48631 1.00000 0.03894 0.21616 0.52643
0.0648 0.0317 0.0347 0.8781 0.3741 0.0206
19 19 19 19 18 19 19
insO 0.39161 0.36935 0.17694 0.03894 1.00000 0.36430
0.22636
0.0973 0.1314 0.4824 0.8781 0.1372 0.3664
19 18 18 18 19 18 18
ins30 -0.11586 0.47724 -0.03523 0.21616 0.36430
1.00000 0.44178
0.6367 0.0388 0.8861 0.3741 0.1372 0.0583
19 19 19 19 18 19 19
ins60 0.23018 0.24355 0.20447 0.52643
0.22636 0.441;8 1.00000
0.3431 0.3150 0.4011 0.0206 0.3664
0.0583
19 19 19 19 18
19 19
ins120 0.05209 0.37404 0.52512
0.40503 0.10375 0.37179 O~9330
0.8323 0.1147 0.0210 0.0854
0.6820 0.1170 0.0957
19 19 19 19 18
19 19
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
glueD glue30 gluc60 glue120 insO ins30 ins60
bmcg
-0.18173 0.00003 0.01766
-0.21909 0.26802 0.29925 -0.04050
0.4432 0.9999 0.9428 0.3675 0.2673 0.2133 0.8692
20 19 19 19 19 19 19
fatg 0.21165 0.22885 0.50114 -0.16261 0.61215 0.13425 0.06201
0.3704 0.3460 0.0288 0.5060 0.0053 0.5837 0.8009
20 19 19 19 19 19 19
leang 0.15129 0.11083 0.02614 0.02806 0.28897 0.36196 0.11130
0.5243 0.6515 0.9154 0.9092 0.2302 0.1278 0.6501
20 19 19 19 19 19 19
totg 0.20149 0.17866 0.22958 -0.05539 0.49629 0.33585 0.10701
0.3943 0.4643 0.3444 0.8218 0.0307 0.1598 0.6628
20 19 19 19 19 19 19
petfat 0.17727 0.19025 0.50606 -0.19085 0.56639 0.05909 0.04316
0.4547 0.4353 0.0271 0.4338 0.0115 0.8101 0.8607
20 19 19 19 19 19 19
Pearson Correlation Coefficients
Prob> Irl under HO: Rho=O
Number of Observations
ins120 bmcg fatg leang totg pctfat
ratid -0.10391 -0.22291 -0.07287 0.02520 -0.02092 ... 0.06485
0.6721 0.3448 0.7601 0.9160 0.9302 0.7859
19 20 20 20 20 20
trmt 0.43926 0.23220 0.78269 0.02401 0.36616 0.80940
0.0599 0.3246 <.0001 0.9200 0.1123 <.0001
19 20 20 20 20 20
lepO -0.09470 0.11395 0.22876 -0.16418 -0.00543 0.24497
0.7371 0.6859 0.4122 0.5587 0.9847 0.3789
15 15 15 15 15 15
lep30 0.45430 -0.01666 0.45869 0.03578 0.24661 0.45553
0.1379 0.9590 0.1337 0.9121 0.4397 0.1367
12 12 12 12 12 1'2
lep60 0.08491 0.32410 0.50810 0.26982 0.42529 0.46714
0.7376 0.1895 0.0313 0.2789 0.0785 0.0506
18 18 18 18 18 18
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Numper of Observations
ins120 bmcg fatg leang totg pctfat
lep120 0.11413 0.32185 0.58201 0.15750 0.36799 0.57727
0.6738 0.2241 0.0180 0.5602 0.1608 0.0192
16 16 16 16 16 16
weight 0.08724 0.86343 0.65484 0.85945 0.96925 0.48342
0.7225 <.0001 0.0017 <.0001 <.0001 0.0308
19 20 20 20 20 20
glucO 0.05209 -0.18173 0.21165 0.15129 0.20149 0.11727
0.8323 0.4432 0.3704 0.5243 0.3943 0.4547
19 20 20 20 20 20
gluc30 0.37404 0.00003 0.22885 0.11083 0.17866 0.19025
0.1147 0.9999 0.3460 0.6515 0.4643 0.4353
19 19 19 19 19 19
gluc60 0.52512 0.01766 0.50114 0.02614 0.22958 0.50606
0.0210 0.9428 0.0288 0.9154 0.3444 0.0271
19 19 19 19 19 19
gluc120 0.40503 -0.21909 -0.16261 0.02806 -0.05539 -0.19085
0.0854 0.3675 0.5060 0.9092 0.8218 0.4338
19 19 19 19 19 19
insO 0.10375 0.26802 0.61215 0.28897 0.49629 0.56639
0.6820 0.2673 0.0053 0.2302 0.0307 0.0115
18 19 19 19 19 19
ins30 0.37179 0.29925 0.13425 0.36196 0.33585 0.05909
0.1170 0.2133 0.5837 0.1278 0.1598 0.8101
19 19 19 19 19 19
ins60 0.39330 -0.04050 0.06201 0.11130 0.10701 0.04316
0.0957 0.8692 0.8009 0.6501 0.6628 0.8607
19 19 19 19 19 19
ins120 1.00000 -0.03398 0.15536 0.01693
0.07668 0.14613
0.8902 0.5254 0.9451 0.7550 0.5505
19 19 19 19 19 19
bmcg -0.03398 1.00000 0.50566 0.83101
0.88739 0.33335
0.8902 0.0229 <.0001 <.0001
0.1509
19 20 20 20 20
20
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Pearson Correlation Coefficients
Prob > I r·1 under HO: Rho=O
Number of Observations
ins120 bmcg fatg leang totg petfat
fatg 0.15536 0.50566 1.00000 0.25731 0.64784 0.97500
0.5254 0.0229 0.2734 0.0020 <.0001
19 20 20 20 20 20
leang 0.01693 0.83101 0.25731 1.00000 0.90265 0.04229
0.9451 <.0001 0.2734 <.0001 0.8595
19 20 20 20 20 20
totg 0.07668 0.88739 0.64784 0.90265 , .00000 0.46713
0.7550 <.0001 0.0020 <.0001 0.0378
19 20 20 20 20 20
petfat 0.14613 0.33335 0.97500 0.04229 0.46713 1.00000
0.5505 0.1509 <.0001 0.8595 0.0378
19 20 20 20 20 20
111)·
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20 Variables: ratid
gluc60
totg
trmt
gluc120
pcttat
lepO
insO
lep30
in530
lep60
1n560
lep120
in5120
weight
bmcg
glueO
fatg
gluc30
leang
Simple Statistics
Variable N Mean Std Dev Sum Minimum Maximum
ratid 20 15.00000 8.85557 300.00000 1.00000 29.00000
trmt 20 1.50000 0.51299 30.00000 1.00000 2.00000
lepO 15 1.43786 0.45223 21.56789 0.80641 2.69970
lep30 12 1.34815 0.36963 16.17775 0.92064 1.98810
lep60 18 1.63558 0.52130 29.44043 0.84110 2.78460
lep120 16 2.11033 0.77930 33.76526 0.97476 4.01190
weight 20 190.94600 12.41382 3819 156.28000 209.53000
glueO 20 102.25000 8.16201 2045 79.00000 115.00000
gluc30 19 189.89474 21.23125 3608 148.00000 237.00000
gluc60 19 206.21053 36.89411 3918 124.00000 301.00000
glue120 19 165.10526 32.19713 3137 106.00000 228.00000
in50 19 1.57057 0.63813 29.84078 0.37882 2.66280
in530 19 2.29511 0.70842 43.60709 0.81409 3.55390
ins60 19 2.09443 0.55522 39.79410 1 .15240 2.98650
ins120 19 1.89972 0.56284 36.09470 0.73220 2.77420
bmeg 20 5.23500 0.42212 104.70000 4.20000 6.00000
tatg 20 21.33000 6.39392 426.60000 12.60000 41 .10000
leang 20 161.84500 9.48359 3237 142.30000 175.70000
totg 20 188.41000 12.03621 3768 160.90000 209.50000
pcttat 20 11.24000 2.89689 224.80000 6.70000 19.70000
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid trmt lepO lep30 lep60 lep120 weight
ratid 1.00000 0.05793 -0.12406 0.08195 -0.08959 0.09519 0.01573
0.8083 0.6596 0.8001 0.7237 0.7258 0.9475
20 20 15 12 18 16 20
trmt 0.05793 1.00000 0.16252 0.53164 0.48507 0.56278 0.44233
0.8083 0.5628 0.0753 0.0413 0.0232 0.0508
20 20 15 12 18 16 20
-0.12406 0.16252 1.00000 0.67920 0.60980 0.81873 -0.02597lepO
0.0308 0.0158 0.0003 &.92680.6596 0.5628
15 15 10 15 14 1515
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Numper of Observations
ratid trmt lepO lap30 lep60 lep120 weight
lep30 0.08195 0.53164 0.67920 1.00000 0.91083 0.88457 0.25726
0.8001 0.0753 0.0308 <.0001 0.0003 0.4195
12 12 10 12 12 11 12
lap60 -0.08959 0.48507 0.60980 0.91083 1.00000 0.89041 0.47613
0.7237 0.0413 0.0158 <.0001 <.0001 0.0458
18 18 15 12 18 16 18
lep120 0.09519 0.56278 0.81873 0.88457 0.89041 1.00000 0.37061
0.7258 0.0232 0.0003 0.0003 <.0001 0.1576
16 16 14 11 16 16 16
weight 0.01573 0.44233 -0.02597 0.25726 0.47613 0.37061 1.00000
0.9475 0.0508 0.9268 0.4195 0.0458 0.1576
20 20 15 12 18 16 20
glueO 0.35680 0.25769 0.12473 0.49369 0.30276 0;25059 0.18754
0.1225 0.2727 0.6578 0.1028 0.2220 0.3492 0.4285
20 20 15 12 18 16 20
gluc30 0.04194 0.32162 0.02201 0.44224 0.32783 0.16708 0.24986
0.8647 0.1794 0.9379 0.1500 0.1841 0.5363 0.3022
19 19 15 12 18 16 19
gluc60 0.29132 0.63373 0.04126 0.42885 0.13008 0.26516 0.25681
0.2262 0.0036 0.8839 0.1642 0.6069 0.3209 0.2885
19 19 15 12 18 16 19
gluc120 0.40684 0.15455 0.12952 0.37288 0.07195 0.14882 -0.04044
0.0839 0.5276 0.6455 0.2326 0.7766 0.5823 0.8694
19 19 15 12 18 16 19
insO -0.12548 0.50094 0.32853 0.75372 0.85256
0.71266 0.54834
0.6087 0.0289 0.2319 0.0046 <.0001 0.0019 0.0151
19 19 15 12 18 16 19
ins30 -0.12850 0.21053 0.04845 0.30865
0.39978 0.20209 0.32708
0.6001 0.3870 0.8639 0.3290 0.1002
0.4529 0.1717
19 19 15 12 18 16
19
1ns60 -0.03845 0.33177 0.05731
-0.02034 0.02158 -0.04608 0-:-11665
0.8758 0.1652 0.8392 0.9500
0.9323 0.8654 0.6344
19 19 15 12
18 16 19
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Numper of Observations
ratid trmt lepO lep30 lap60 lep120 weight
ins120 -0.10391 0.43926 ·0.09470 0.45430 0.08491 0.11413 0.08724
0.6721 0.0599 0.7371 0.1379 0.7376 0.6738 0.7225
19 19 15 12 18 16 19
bmeg -0.26892 0.27951 0.04940 0.03298 0.35376 0.31345 0.82094
0.2516 0.2327 0.8612 0.9190 0.1498 0.2371 <.0001
20 20 15 12 18 16 20
fatg -0.12865 0.68678 0.20710 0.58355 0.49120 0.53575 0.56707
0.5888 0.0008 0.4589 0.0464 0.0384 0.0324 0.0091
20 20 15 12 18 16 20
leang -0.07796 -0.03624 0.02614 0.00175 0.24063 0.17948 0.75890
0.7439 0.8794 0.9263 0.9957 0.3361 0.5060 0.0001
20 20 15 12 18 16 20
totg -0.13861 0.34608 0.13622 0.31436 0.43932 0.40594 0.92766
0.5600 0.1350 0.6283 0.3197 0.0681 0.1187 <.0001
20 20 15 12 18 16 20
pctfat -0.11530 0.69770 0.18551 0.57672 0.45263 0.50264 0.41628
0.6283 0.0006 0.5080 0.0496 0.0593 0.0472 0.0679
20 20 15 12 18 16 20
Pearson Correlation Coefficients
Prob> Irl under HO: Rho=O
Number of Observations
glueO gluc30 gluc60 gluc120 1nsO 1ns30 ins60
ratid 0.35680 0.04194 0.29132 0.40684 -0.12548
-0.12850 -0.03845
0.1225 0.8647 0.2262 0.0839 0.6087 0.6001 0.8758
20 19 19 19 19 19 19
trmt 0.25769 0.32162 0.63373 0.15455
0.50094 0.21053 0.33177
0.2727 0.1794 0.0036 0.5276 0.0289
0.3870 0.1652
20 19 19 19 19
19 19
lepO 0.12473 0.02201 0.04126 0.12952
0.32853 0.04845 0.05731
0.6578 0.9379 0.8839 0.6455
0.2319 0.8639 0.8392
15 15 15 15
15 15 15
lep30 0.49369 0.44224 0.42885
0.37288 0.75372 0.30865 -0.02034
0.1028 0.1500 0.1642
0.2326 0.0046 0.3290 0.9500
12 12 12
12 12 12 12
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Numper of Observations
glucO gluc30 gluC60 gluc120 insO ins30 in560
lep60 0.30276 0.32783 0.13008 0.07195 0.85256 0.39978 0.02158
0.2220 0.1841 0.6069 0.7766 <.0001 0.1002 0.9323
18 18 18 18 18 18 18
lep120 0.25059 0.16708 0.26516 0.14882 0.71266 0.20209 -0.04608
0.3492 0.5363 0.3209 0.5823 0.0019 0.4529 0.8654
16 16 16 16 16 16 16
weight 0.18754 0.24986 0.25681 -0.04044 0.54834 0.32708 0.11665
0.4285 0.3022 0.2885 0.8694 0.0151 O. 1717 0.6344
20 19 19 19 19 19 19
glueO 1.00000 0.33997 0.42245 0.43194 0.39161 -0.11586 0.23018
0.1544 0.0716 0.0648 0.0973 0.6367 0.3431
20 19 19 19 19 19 19
gluc30 0.33997 1 .00000 0.53572 0.49374 0.36935 0.47724 0.24355
0.1544 0.0181 0.0317 0.1314 0.0388 0.3150
19 19 19 19 18 19 19
glue60 0.42245 0.53572 1.00000 0.48637 0.17694 -0.03523 0.20447
0.0716 0.0181 0.0347 0.4824 0.8861 0.4011
19 19 19 19 18 19 19
gluc120 0.43194 0.49374 0.48637 1.00000 0.03894 0.21616 0.52643
0.0648 0.0317 0.0347 0.8781 0.3741 0.0206
19 19 19 19 18 19 19
insO 0.39161 0.36935 0.17694 0.03894 1.00000 0.36430
0.22636
0.0973 0.1314 0.4824 0.8781 0.1372 0.3664
19 18 18 18 19 18 18
ins30 -0.11586 0.47724 -0.03523 0.21616 0.36430
1.00000 0.44178
0.6367 0.0388 0.8861 0.3741 0.1372 0.0583
19 19 19 19 18 19
19
ins60 0.23018 0.24355 0.20447 0.52643
0.22636 0.44178 1.00000
0.3431 0.3150 0.4011 0.0206 0.3664
0.0583
19 19 19 19 18
19 19
in8120 0.05209 0.37404 0.52512
0.40503 0.10375 0.37179 0~9330
0.8323 0.1147 0.0210 0.0854
0.6820 0.1170 0.0957
19 19 19 19
18 19 19
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
glueO gluc30 gluc60 gluc120 i050 in530 ins60
bmcg
-0.23029 0.01443 0.05025 -0.38417 0.37826 0.24483 -0.16599
0.3287 0.9533 0.8381 0.1044 0.1103 0.3124 0.4970
20 19 19 19 19 19 19
fatg 0.17654 0.31156 0.51902 -0.22814 0.60683 0.10199 -0.06540
0.4565 0.1941 0.0228 0.3475 0.0059 0.6778 0.7902
20 19 19 19 19 19 19
leang -0.05625 -0.06360 -0.04719 -0.02272 0.12463 0.20995 -0.01242
0.8138 0.7959 0.8479 0.9264 0.6112 0.3883 0.9598
20 19 19 19 19 19 19
totg 0.04037 0.10844 0.22686 -0.14526 0.42723 0.22087 -0.04800
0.8658 0.6586 0.3503 0.5529 0.0681 0.3635 0.8453
20 19 19 19 19 19 19
petfat 0.17407 0.31683 0.52967 -0.23893 0.58985 0.07243 -0.05687
0.4630 0.1863 0.0197 0.3246 0.0079 0.7682 0.8171
20 19 19 19 19 19 19
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
in5120 bmeg fatg leang totg pctfat
ratid -0.10391 -0.26892 -0.12865 -0.07796 -a .13861 -0.11530
0.6721 0.2516 0.5888 0.7439 0.5600 0.6283
19 20 20 20 20 20
trmt 0.43926 0.27951 0.68678 -0.03624 0.34608 0.69770
0.0599 0.2327 0.0008 0.8794 0.1350 0.0006
19 20 20 20 20 20
lepO -0.09470 0.04940 0.20710 0.02614 0.13622 0.18551
0.7371 0.8612 0.4589 0.9263 0.6283 0.5080
15 15 15 15 15 15
lap30 0.45430 0.03298 0.58355 0.00175 0.31436 0.57672
0.1379 0.9190 0.0464 0.9957 0.3197 0.0496
12 12 12 12 12 t2
0.08491 0.35376 0.49120 0.24063 0.43932 0.45263lep60
0.7376 0.1498 0.0384 0.3361 0.0681 0.0593
18 18 18 18 18 18
Correlations Among Variables
OGTT 2 to DXA 2
The SAS System 15:03 Thursday, May 9, 2002 17
The CORR Procedure
Pearson Correlation Coefficients
Prob> Irl under HO: Rho=O
Numper of Observations
ins120 bmeg fatg leang totg petfat
lep120 0.11413 0.31345 0.53575 0.17948 0.40594 0.50264
0.6738 0.2371 0.0324 0.5060 0.1187 0.0472
16 16 16 16 16 16
weight 0.08724 0.82094 0.56707 0.75890 0.92766 0.41628
0.7225 <.0001 0.0091 0.0001 <.0001 0.0679
19 20 20 20 20 20
glueO 0.05209 -0.23029 0.17654 -0.05625 0.04037 0.17407
0.8323 0.3287 0.4565 0.8138 0.8658 0.4630
19 20 20 20 20 20
glue30 0.37404 0.01443 0.31156 -0.06360 0.10844 0.31683
0.1147 0.9533 0.1941 0.7959 0.6586 0.1863
19 19 19 19 19 19
glue60 0.52512 0.05025 0.51902 -0.04719 0.22686 0.52967
0.0210 0.8381 0.0228 0.8479 0.3503 0.0197
19 19 19 19 19 19
glue120 0.40503 -0.38417 -0.22814 -0.02272 -0.14526 -0.23893
0.0854 0.1044 0.3475 0.9264 0.5529 0.3246
19 19 19 19 19 19
insO 0.10375 0.37826 0.60683 0.12463 0.42723 0.58985
0.6820 0.1103 0.0059 0.6112 0.0681 0.0079
18 19 19 19 19 19
ins30 0.37179 0.24483 0.10199 0.20995 0.22087 0.07243
0.1170 0.3124 0.6778 0.3883 0.3635 0.7682
19 19 19 19 19 19
ins60 0.39330 -0.16599 -0.06540 -0.01242
-0.04800 -0.05687
0.0957 0.4970 0.7902 0.9598 0.8453 0.8171
19 19 19 19 19 19
ins120 1.00000 0.05805 0.34151
-0.06562 0.12330 0.34546
0.8134 0.1524 0.7895 0.6150 0.1474
19 19 19 19 19
19
bmeg 0.05805 1.00000 0.61073
0.66826 0.88563 0.48429
0.8134 0.0042 0.0013
<.0001 0.0305
19 20 20 20
20 20
Correlations Among Variables
OGTT 2 to DXA 2
The SAS System 15:03 Thursday, May 9) 2002 18
The CORR Procedure
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ins120 bmcg fatg leang totg pctfat
fatg 0.34151 0.61073 1.00000 0.04343 0.58613 0.97874
0.1524 0.0042 0.8557 0.0066 <.0001
19 20 20 20 20 20
leang -0.06562 0.66826 0.04343 1.00000 0.83474 -0.15398
0.7895 0.0013 0.8557 <.0001 0.5169
19 20 20 20 20 20
totg 0.12330 0.88563 0.58613 0.83474 1.00000 0.41477
0.6150 <.0001 0.0066 <.0001 0.0690
19 20 20 20 20 20
pctfat 0.34546 0.48429 0.97874 -0.15398 0.41477 1.00000
0.1474 0.0305 <.0001 0.5169 0.0690
19 20 20 20 20 20
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20 Variables: ratid
gluc60
totg
trmt
glue120
pettat
lepO
insO
lep30
in530
lep60 -
ins60
lep120
ins120
weight
bmcg
glueO
fatg
glue30
leang
Simple Statistics
Variable N Mean Std Oev Sum Minimum Maximum
ratid 20 15.00000 8.85557 300.00000 1 .00000 29.00000
trmt 20 1.50000 0.51299 30.00000 1.00000 2.00000
lepO 17 1.42148 0.46635 24.16524 0.85490 2.67470
lep30 16 1.39023 0.67548 22.24372 0.62688 2.92510
lep60 17 1 .70877 0.68787 29.04903 0.67437 3.55810
lep120 16 2.12896 0.89508 34.06336 0.98636 3.80220
weight 19 211.68579 14.45317 4022 171 .55000 233.16000
glueD 18 110.83333 14.08065 1995 88.00000 141.00000
glue3Q 17 181.94118 32.32737 3093 145.00000 246.00000
glue60 17 191.23529 19.25659 3251 165.00000 235.00000
gluC120 17 174.76471 38.89654 2971 107.00000 249.00000
insO 16 0.79545 0.40497 12.72713 0.13189 1.47860
ins30 16 1.65396 0.60033 26.46339 0.33167 2.48250
ins60 16 1.35270 0.47516 21.64321 0.43490 2.19300
ins120 16 1.27303 0.61559 20.36852 0.26565 2.10880
bmcg 20 6.05500 0.46394 121.10000 4.90000 6.90000
fatg 20 23.59500 6.20683 471.90000 16.20000 35.-00000
leang 20 183.25500 10.89517 3665 153.70000 197.30000
totg 20 212.89000 14.26217 4258 174.80000 236.20000
petfat 20 11.00500 2.46544 220.10000 7.50000 15.60000
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid trmt lepO lep30 lep60 lep120 weight
ratid 1 .00000 0.05793 -0.24825 0.02493 -0.06704
0.01138 0.02508
0.8083 0.3367 0.9270 0.7982 0.9666 0.9188
20 20 17 16 17
16 19
0.05793 1.00000 0.50501 0.35540 0.69618
0.73439 0.45522
trmt
0.8083 0.0387 0.1767
0.0019 0.0012 0.0502
20 17 16 17 16
19
20
0.50501 1.00000 0.73715 0.77867
0.62967 0.52884
lepO -0.24825 0.0011 0.0002 0.0090 0.02910.3367 0.0387 16 17
17 17 16 1717
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid trmt lepO lep30 lep60 lep120 weight
lep30 0.02493 0.35540 0.73715 1.00000 0.73355 0.54873 0.39345
0.9270 0.1767 0.0011 0.0012 0.0342 0.1316
16 16 16 16 16 15 16
lep60 -0.06704 0.69618 0.77867 0.73355 1.00000 0.81479 0.42613
0.7982 0.0019 0.0002 0.0012 0.0001 0.08S1
17 17 17 16 17 16 17
lep120 0.01138 0.73439 0.62967 0.54873 0.81479 1.00000 0.45508
0.9666 0.0012 0.0090 0.0342 0.0001 0.0765
16 16 16 15 16 16 16
weight 0.02508 0.45522 0.52884 0.39345 0.42613 0.45508 1.00000
0.9188 0.0502 0.0291 0.1316 0.0881 0.0765
19 19 17 16 17 16 19
glueO -0.12438 0.21788 0.26565 0.38312 0.37373 0.55427 -0.02290
0.6229 0.3851 0.3027 0.1430 O. 1395 0.0259 0.9281
18 18 17 16 17 16 18
gluc30 -0.36149 -0.08068 -0.11302 0.10577 0.08089 0.03719 -0.27674
0.1540 0.7582 0.6658 0.6966 0.7576 0.8912 0.2822
17 17 17 16 17 16 17
gluc60 0.02973 0.20113 -0.18506 -0.13679 0.00427 0.13393 -0.11215
0.9098 0.4389 0.4770 0.6135 0.9870 0.6209 0.6683
17 17 17 16 17 16 17
gluc120 -0.12040 -0.15266 0.24786 0.35106 0.08921 0.20708
0.07688
0.6453 0.5586 0.3375 0.1825 0.7335 0.4416 0.7693
17 17 17 16 17 16 17
in50 -0.01314 0.67116 0.68081 0.50295 0.69519
0.73950 0.76024
0.9615 0.0044 0.0037 0.0560 0.0028 0.0016
0.0006
16 16 16 15 16 15
16
in530 -0.15126 0.39343 0.33322 0.06257
0.09372 0.11546 0.34590
0.5760 0.1316 0.2072 0.8247 0.7299
0.6820 0.1894
16 16 16 15 16
lS 16
in560 -0.31792 0.16410 0.29854
0.04303 0.32242 -0.08748 0.12551
0.2301 0.5437 0.2614 0.8790
0.2233 0.7566 0.6432
16 16 16 15
16 15 16
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Pearson Correlation Coefficients
Prob > 11"1 under HO: Rho=O
Number of Observations
ratid trmt lepO lep30 lep60 lep120 weight
ins120 -0.42642 .0.27696 0.25819 -0.02105 0.20982 -0.07107 0.22782
0.0995 0.2990 0.3343 0.9406 0.4354 0.8013 0.3961
16 16 16 1"5 16 15 16
bmcg -0.22291 0.23220 0.45255 0.26852 0.22043 0.07239 0.87665
0.3448 0.3246 0.0681 0.3146 0.3952 0.7899 . <.0001
20 20 17 16 17 16 19
fatg -0.07287 0.78269 0.55902 0.43461 0.69232 0.69827 0.63566
0.7601 <.0001 0.0197 0.0925 0.0021 0.0026 0.0034
20 20 17 16 17 16 19
leang 0.02520 0.02401 0.34548 0.24002 0.13414 -0.01185 0.89274
0.9160 0.9200 0.1744 0.3706 0.6078 0.9653 <.0001
20 20 17 16 17 16 19
totg -0.02092 0.36616 0.50850 0.38097 0.39915 0.35543 0.98817
0.9302 0.1123 0.0371 0.1454 0.1125 0.1767 <.0001
20 20 17 16 17 16 19
pctfat -0.06485 0.80940 0.50117 0.38228 0.68066 0.71049 0.45969
0.7859 <.0001 0.0404 0.1439 0.0026 0.0020 0.0477
20 20 17 16 17 16 19
Pearson Correlation Coefficients
Prob > lrl under HO: Rho=O
Number of Observations
glueO gluc30 gluc60 gluc120 insO in530 in560
'ratid -0.12438 -0.36149 0.02973 -0.12040 -0.0131.4 -0.15126
-0.31792
0.6229 0.1540 0.9098 0.6453 0.9615 0.5760 0.2301
18 17 17 17 16 16 16
trmt 0.21788 -0.08068 0.20'13 ·0.15266
0.67116 0.39343 0.16410
0.3851 0.7582 0.4389 0.5586 0.0044
0.1316 0.5437
18 17 17 17 16
16 16
lepO 0.26565 -0.11302 -0.18506
0.24786 0.68081 0.33322 0.29854
0.3027 0.6658 0.4770 0.3375 0.0037
0.2072 0.2614
17 17 17 17
16 16 16
lep30 0.38312 0.10577 -0.13679
0.35106 0.50295 0.06257 0.04303
0.1430 0.6966 0.6135 0.1825
0.0560 0.8247 0.8790
16 16 16 16
15 15 15
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Pearson Correlation Coefficients
Prob > Irl under HO: Aho=O
Number of Observations
glueo gluC30 gluC60 gluc120 insO ins30 ins60
lep60 0.37373 0.08089 0.00427 0.08921 0.69519 0.09372 0.32242
O. 1395 0.7576 0.9870 0.7335 0.0028 0.7299 0.2233
17 17 17 17 16 16 16
lep120 0.55427 0.03719 0.13393 0.20708 0.73950 0.11546 -0.08748
0.0259 0.8912 0.6209 0.4416 0.0016 0.6820 0.7566
16 16 16 16 15 15 15
weight
-0.02290
-0.27674 -0.11215 0.07688 0.76024 0.34590 0.12551
0.9281 0.2822 0.6683 0.7693 0.0006 0.1894 0.6432
18 17 17 17 16 16 16
glueO 1.00000 0.49588 0.67358 0.66229 0.22850 -0.00611 -0.53920
0.0429 0.0030 0.0038 0.3946 0.9821 0.0311
18 17 17 17 16 16 16
glue30 0.49588 1.00000 0.57350 0.12574 -0.20228 -0.37986 -0.02393
0.0429 0.0161 0.6306 0.4525 0.1467 0.9299
17 17 17 17 16 16 16
glue60 0.67358 0.57350 1.00000 0.42906 -0.04320 0.05038 -0.27462
0.0030 0.0161 0.0857 0.8738 0.8530 0.3033
17 17 17 17 16 16 16
glue120 0.66229 0.12574 0.42906 1.00000 0.23383 0.14115 -0.52210
0.0038 0.6306 0.0857 0.3834 0.6021 0.0380
17 17 17 17 16 16 16
insO 0.22850 -0.20228 -0.04320 0.23383 1.00000 0.18136 0.09578
0.3946 0.4525 0.8738 0.3834 0.5015 0.7242
16 16 16 16 16 16 16
ins30 -0.00611 -0.37986 0.05038 0.14115 0.18136 1.00000 0.08613
0.9821 0.1467 0.8530 0.6021 0.5015 0.7511
16 16 16 16 16 16 16
ins60 -0.53920 -0.02393 -0.27462 -0.52210 0.09578 0.08613 1.00000
0.0311 0.9299 0.3033 0.0380 0.7242 0.7511
16 16 16 16 16 16 16
ins120 -0.22321 -0.06742 -a .15626 -0.32216 0.02443 0.46298 0.62699
0.4060 0.8041 0.5633 0.2237 0.9284 0.0709 0.0093
16 16 16 16 16 16 16
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Pearson Correlation Coefficients
Prob > frl under HO: Rho=O
Number of Observations
glueO glue30 gluc60 gluC120 insO 1n530 in560
bmcg
-0.30266
-0.32987
-0.29101 0.02092 0.57071 0.39041 0.31493
0.2222 0.1960 0.2571 0.9365 0.0210 0.1349 0.2348
18 17 17 17 16 16 16
fatg 0.11448
-0.23669
-0.11828 -0.05989 0.82048 0.31060 0.17464
0.6510 0.3604 0.6512 ~ . . 0.8194 <.0001 0.2416 0.5177
18 17 17 17 16 16 16
leang
-0.11213
-0.25668
-0.13157 0.14549 0.51733 0.26621 0.09148
0.6578 0.3200 0.6147 0.5774 0".0401 0.3190 0.7362
18 17 17 17 16 16 16
totg
-0.04473 ·0.30089 -0.15740 0.08316 0.74595 0.33952 0.15251
0.8601 0.2406 0.5463 0.7510 0.0009 0.1982 0.5728
18 17 17 17 16 16 16
petfat 0.14307 -0.19877 -0.09637 -0.10810 0.74015 0.28743 0.14357
0.5712 0.4444 0.7129 0.6796 0.0010 0.2804 0.5958
18 17 17 17 16 16 16
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
1ns120 bmeg fatg leang totg pctfat.
ratid -0.42642 -0.22291 -0.07287 0.02520 -0.02092 -0.06485
0.0995 0.3448 0.7601 0.9160 0.9302 0.7859
16 20 20 20 20 20
trmt 0.27696 0.23220 0.78269 0.02401 0.36616 0.80940
0.2990 0.3246 <.0001 0.9200 0.1123 <.0001
16 20 20 20 20 20
lepO 0.25819 0.45255 0.55902 0.34548 0.50850 0.50117
0.3343 0.0681 0.0197 0.1744 0.0371 0.0404
16 17 17 17 17 17
lep30 -0.02105 0.26852 0.43461 0.24002 0.38097 0.38228
0.9406 0.3146 0.0925 0.3706 0.1454 0.1439
15 16 16 16 16 16
lep60 0.20982 0.22043 0.69232 0.13414 0.39915 0.68066
0.4354 0.3952 0.0021 0.6078 0.1125 0.0026
16 17 17 17 17 17
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
in5120 bmeg fatg leang totg pettat
lep120
-0.07107 0.07239 0.69827 -0.01185 0.35543 0.71049
0.8013 0.7899 0.0026 0.9653 0.1767 0.0020
15 16 16 16 16 16
weight 0.22782 0.87665 0.63566 0.89274 0.98817 0.45969
0.3961 <.0001 0.0034 <.0001 <.0001 0.0477
16 19 19 19 19 19
glueO -0.22321 -0.30266 0.11448 -0.11213 -0.04473 0.14307
0.4060 0.2222 0.6510 0.6578 0.8601 0.5712
16 18 18 18 18 18
gluc30 -0.06742 -0.32987 -0.23669 -0.25668 -0.30089 -0.19877
0.8041 0.1960 0.3604 0.3200 0.2406 0.4444
16 17 17 17 17 17
gluc60 -0.15626 -0.29101 -0.11828 -0.13157 -0.15740 -0.09637
0.5633 0.2571 0.6512 0.6147 0.5463 0.7129
16 17 17 17 17 17
glue120 -0.32216 0.02092 -0.05989 0.14549 0.08316 -0.10810
0.2237 0.9365 0.8194 0.5774 0.7510 0.6796
16 17 17 17 17 17
in50 0.02443 0.57071 0.82048 0.51733 0.74595 0.74015
0.9284 0.0210 <.0001 0.0401 0.0009 0.0010
16 16 16 16 16 16
in530 0.46298 0.39041 0.31060 0.26621 0.33952 0.28743
0.0709 0.1349 0.2416 0.3190 0.1982 0.2804
16 16 16 16 16 16
ins60 0.62699 0.31493 0.17464 0.09148 0.15251
0.14357
0.0093 0.2348 0.5177 0.7362 0.5728 0.5958
16 16 16 16 16 16
ins120 1.00000 0.28486 0.29435 0.17557
0.26368 0.27902
0.2849 0.2684 0.5154 0.3237 0.2953
16 16 16 16 16
16
bmeg 0.28486 1.00000 0.50566
0.83101 0.88739 0.33335
0.2849 0.0229 <.0001
<.0001 0.1509
16 20 20 20 20
20
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Pearson Correlation Coefficients
Prob> Irl under HO: Rho=O
Number of Observations
ins120 bmeg fatg leang totg petfat
fatg 0.29435 0.50566 1.00000 0.25731 0.64784 0·.97500
0.2684 0.0229 0.2734 0.0020 <.0001
16 20 20 20 20 20
leang 0.17557 0.83101 0.25731 1.00000 0.90265 0.04229
0.5154 <.0001 0.2734 <.0001 0.8595
16 20 20 20 20 20
totg 0.26368 0.88739 0.64784 0.90265 1.00000 0.46713
0.3237 <.0001 0.0020 <.0001 0.0378
16 20 20 20 20 20
pettat 0.27902 0.33335 0.97500 0.04229 0.46713 1.00000
0.2953 0.1509 <.0001 0.8595 0.0378
16 20 20 20 20 20
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20 Variables: ratid trmt lepO lep30 lep60 lep120 weight glueD gluc30
glue60 glue120 insO ins30 ins60 ins120 bmcg fatg leang
totg pctfat
Simple Statistics
Variable N Mean Std Dev Sum Minimum Maximum
ratid 20 15.00000 8.85557 300.00000 1.00000 29.00000
trmt 20 1.50000 0.51299 30.00000 1.00000 2.00000
lepO 17 1.42148 0.46635 24.16524 0.85490 2.67470
lep30 16 1.39023 0.67548 22.24372 0.62688 2.92510.
lep60 17 1.70877 0.68787 29.04903 0.67437 3.55810
lep120 16 2.12896 0.89508 34.06336 0.98636 3.80220
weight 19 211.68579 14.45317 4022 171.55000 233.16000
glueO 18 110.83333 14.08065 1995 88.00000 141.00000
gluc30 17 181.94118 32.32737 3093 145.00000 246.00000
gluc60 17 191.23529 19.25659 3251 165.00000 235.00000
gluC120 17 174.76471 38.89654 2971 107.00000 249.00000
insO 16 0.79545 0.40497 12.72713 0.13189 1 .47860
ins30 16 1.65396 0.60033 26.46339 0.33167 2.48250
ins60 16 1.35270 0.47516 21.64321 0.43490 2.19300
ins120 16 1.27303 0.61559 20.36852 0.26565 2.10880
bmcg 19 6.74211 0.54090 128.10000 5.20000 7.80000
fatg 19 24.86316 7.13631 472.40000 14.80000 38.60000
leang 19 192.87895 11.77793 3665 164.70000 208.20000
totg 19 224.46842 15.03308 4265 184.70000 246.50000
pctfat 19 11.01053 2.74568 209.20000 7.50000 15.80000
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid
trmt
lepO
ratid trmt lepO lep30 lep60 lep120 eight
1.00000 0.05793 -0.24825 0.02493 -0.06704 0.01138 0.02508
0.8083 0.3367 0.9270 0.7982 0.9666 0.9188
20 20 17 16 17 16 19
0.05793 1 .00000 0.50501 0.35540 0.69618 0.73439 0.45522
0.8083 0.0387 0.1767 0.0019 0.0012 0.0502
20 20 17 16 17 16 19
-0.24825 0.50501 1 .00000 0.73715 0.77867 0.62967 0.52884
0.3367 0.0387 0.0011 0.0002 0.0090 0".0291
17 17 17 16 17 16 17
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
ratid trmt lepO lep30 lep60 lep120 weight
lep30 0.02493 0.35540 0.73715 1.00000 0.73355 0.54873 0.39345
0.9270 0.1767 0.0011 0.0012 0.0342 0.1316
16 16 16 16 16 15 16
lep60
-0.06704 0.69618 0.77867 0.73355 1.00000 0.81479 0.42613
0.7982 0.0019 0.0002 0.0012 0.0001 0.0881
17 11 17 16 17 16 17
lep120 0.01138 0.73439 0.62967 0.54873 0.81479 1.00000 0.45508
0.9666 0.0012 0.0090 0.0342 0.0001 0.0765
16 16 16 15 16 16 16
weight 0.02508 0.45522 0.52884 0.39345 0.42613 0.45508 1.00000
0.9188 0.0502 0.0291 0.1316 0.0881 0.0765
19 19 17 16 11 16 19
glueO ·0.12438 0.21788 0.26565 0.38312 0.37373 0.55427 -0.02290
0.6229 0.3851 0.3027 0.1430 0.1395 0.0259 0.9281
18 18 17 16 17 16 18
gluc30 -0.36149 -0.08068 -0.11302 0.10577 0.08089 0.03719 -0.27674
0.1540 0.7582 0.6658 0.6966 0.7576 0.8912 0.2822
17 17 17 16 17 16 17
..
gluc60 0.02973 0.20113 ·0.18506 ·0.13679 0.00427 0.13393 -0.11215
0.9098 0.4389 0.4770 0.6135 0.9810 0.6209 0.6683
17 17 17 16 17 16 17
gluc120 ·0.12040 ·0.15266 0.24786 0.35106 0.08921 0.20708 0.07688
0.6453 0.5586 0.3375 0.1825 0.7335 0.4416 0.7693
17 17 17 16 17 16 17
insO ·0.01314 0.67116 0.68081 0.50295 0.69519 0.73950 0.76024
0.9615 0.0044 0.0037 0.0560 0.0028 0.0016 0.0006
16 16 16 15 16 15 16
ins30 ·0.15126 0.39343 0.33322 0.06257 0.09372 0.11546 0.34590
0.5760 0.1316 0.2072 0.8247 0.7299 0.6820 0.1894
16 16 16 15 16 15 16
ins60 -0.31792 0.16410 0.29854 0.04303 0.32242 .. 0.08748 0:-12551
0.2301 0.5437 0.2614 0.8790 0.2233 0.7566 0.6432
16 16 16 15 16 15 16
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Pearson Correlation Coefficients
Prob > frl under HO: Rho=O
Numper of Observations
ratid trmt lepO lep30 lap60 lep120 weight
ins120
-0.42642 0.27696 0.25819 -0.02105 0.20982 -0.07107 0.22782
0.0995 0.2990 0.3343 0.9406 0.4354 0.8013 0.3961
16 16 16 15 16 15 16
bmcg
-0.11803 0.23605 0.44750 0.25577 0.32939 0.08616 0.89134
0.6304 0.3306 0.0717 0.3390 0.1967 0.7510 <.0001
19 19 17 16 17 16 19
fatg 0.01095 0.79624 0.63343 0.52511 0.75546 0.71905 0.67155
0.9645 <.0001 0.0063 0.0367 0.0005 0.0017 0.0016
19 19 17 16 17 16 19
leang 0.01984
-0.06151 0.17963 0.10932 -0.03455 -0.13417 0.78277
0.9358 0.8025 0.4903 0.6869 0.8953 0.6203 <.0001
19 19 17 16 17 16 19
totg 0.01706 0.33726 0.44200 0.35099 0.34101 0.32692 0.96213
0.9447 0.1579 0.0757 0.1825 0.1804 0.2165 <.0001
19 19 17 16 17 16 19
petfat 0.02977 0.82415 0.61173 0.50865 0.777,60 0.73992 0.52934
0.9037 <.0001 0.0091 0.0442 0.0002 0.0010 0.0198
19 19 17 16 17 16 19
Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
glueO gluc30 gluc60 gluc120 insO ins30 ins'50
ratid -0.12438 -0.36149 0.02973 -0.12040 -0.01314 -0.15126 -0.31792
0.6229 0.1540 0.9098 0.6453 0.9615 0.5760 0.2301
18 17 17 17 16 16 16
trmt 0.21788 -0.08068 0.20113 -0.15266 0.67116 0.39343 0.16410
0.3851 0.7582 0.4389 0.5586 0.0044 0.1316 0.5437
18 17 17 17 16 16 16
lepO 0.26565 -0.11302 -0.18506 0.24786 0.68081 0.33322 0.29854
0.3027 0.6658 0.4770 0.3375 0.0037 0.2072 0.2614
17 17 17 17 16 16 16
lep30 0.38312 0.10577 -0.13679 0.35106 0.50295 0.06257 0.04303
0.1430 0.6966 0.6135 0.1825 0.0560 0.8247 0.879E>
16 16 16 16 15 15 15
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Pearson Correlation Coefficients
Prob> Irl under HO: Rho=O
Number of Observations
glucO gluc30 gluc60 gluc120 1nsO in530 1ns60
lep60
.0.37373 0.08089 0.00427 0.08921 0.69519 0.09372 0.32242
0.1395 0.7576 0.9870 0.7335 0.0028 0.7299 0.2233
17 17 17 17 16 16 16
lep120 0.55427 0.03719 0.13393 0.20708 0.73950 0.11546 -0.08748
0.0259 0.8912 0.6209 0.4416 0.0016 0.6820 0.7566
16 16 16 16 15 15 15
weight
-0.02290
-0.27674
-0.11215 0.07688 0.76024 0.34590 O. 12551
0.9281 0.2822 0.6683 0.7693 0.0006 0.1894 0.6432
18 17 17 17 16 16 16
glueO 1.00000 0.49588 0.67358 0.66229 0.22850 -0.00611 -0.53920
0.0429 0.0030 0.0038 0.3946 0.9821 0.0311
18 17 17 17 16 16 16
g!uc30 0.49588 1.00000 0.57350 0.12574 -0.20228 -0.37986 -0.023'93
0.0429 0.0161 0.6306 0.4525 0.1467 0.9299
17 17 17 17 16 16 16
g!uc60 0.67358 0.57350 1.00000 0.42906 -0.04320 0.05038 -0.27462
0.0030 0.0161 0.0857 0.8738 0.8530 0.3033
17 17 17 17 16 16 16
gluc120 0.66229 0.12574 0.42906 1.00000 0.23383 0.14115 -0.52210
0.0038 0.6306 0.0857 0.3834 0.6021 0.0380
17 17 17 17 16 16 16
1nsO 0.22850 -0.20228 -0.04320 0.23383 1 .00000 0.18136 0.09578
0.3946 0.4525 0.8738 0.3834 0.5015 0.7242
16 16 16 16 16 16 16
1n530 -0.00611 -0.37986 0.05038 0.14115 0.18136 1.00000 0.08613
0.9821 0.1467 0.8530 0.6021 0.5015 0.7511
16 16 16 16 16 16 16
1ns60 -0.53920 -0.02393 -0.27462 -0.52210 0.09578 0.08613 1.00000
0.0311 '0.9299 0.3033 0.0380 0.7242 0.7511
16 16 16 16 16 16 ·16
ins120 -0.22321 -0.06742 -0.15626 -0.32216 0.02443 0.46298 0:"62699
0.4060 0.8041 0.5633 0.2237 0.9284 0.0709 0.0093
16 16 16 16 16 16 16
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Pearson Correlation Coefficients
Prob > rl under HO: Rho=O
Number of Observations
glueO gluc30 gluc60 gluc120 insO ins30 ins60
bmcg
-0.21170
-0.23701
-0.20845 -0.07037 0.59290 0.33728 0.39444
0.3990 0.3597 0.4220 0.7884 0.0155 0.2014 0.1306
18 17 17 17 16 16 16
fatg 0.04262
-0.27623
-0.19949 -0.02396 0.89242 0.20519 0.22858
0.8667 0.2832 0.4427 0.9273 <.0001 0.4459 0.3945
18 17 17 17 16 16 16
leang
-0.08617
-0.27128 .. 0.10043 0.07003 0.37527 0.34743 0.,00890
0.7339 0.2922 0.7013 0.7894 O. 1521 0.1873 0,,9739
18 17 17 17 16 16 16
totg
-0.05404
-0.33378 .. 0.17453 0.03575 0.70791 0.35572 0.12839
0.8313 0.1904 0.5029 0.8916 0.0022 0.1763 0.6356
18 17 17 17 16 16 16
pctfat 0.04031 ·0.23495 -0.19101 ·0.06131 0.85807 0.16158 0.22853
0.8738 0.3640 0.4627 0.8152 <.0001 0.5499 0.3946
18 17 17 17 16 16 16
Pearson Correlation Coefficients
Prob > (rl under HO: Rho=O
Number of Observations
ins120 bmcg fatg leang totg pctfat
ratid -0.42642 -0.11803 0.01095 0.01984 0.01706 0.02977
0.0995 0.6304 0.9645 0.9358 0.9447 0.9037
16 19 19 19 19 19
trmt 0.27696 0.23605 0.79624 -0.06151 0.33726 0.82415
0.2990 0.3306 <.0001 0.8025 0.1579 <.0001
16 19 19 19 19 19
lepO 0.258"19 0.44750 0.63343 0.17963 0.44200 0.61173
0.3343 0.0717 0.0063 0.4903 0.0757 0.0091
16 17 17 17 17 17
lep30 -0.02105 0.25577 0.52511 0.10932 0.35099 0.50865
0.9406 0.3390 0.0367 0.6869 0.1825 0.0442
15 16 16 16 16 t6
lep60 0.20982 0.32939 0.75546 -0.03455 0.34101 0.77760
0.4354 0.1967 0.0005 0.8953 0.1804 0.0002
16 17 17 17 17 17
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Pearson Correlation Coefficients
Prob> Irl under HO: Rho=O
Numper of Observations
ins120 bmcg fatg leang totg pctfat
lep120
-0.07107 0.08616 0.71905 -0.13417 0.32692 0.73992
0.8013 0.7510 0.0017 0.6203 0.2165 0.0010
15 16 16 16 16 16
weight 0.22782 0.89134 0.67155 0.78277 0.96273 0.52934
0.3961 <.0001 0.0016 <.0001 <.0001 0.0198
16 19 19 19 19 19
glueO
-0.22321
-0.21170 0.04262 -0.08617 -0.05404 0.04031
0.4060 0.3990 0.8667 0.7339 0.8313 0.8738
16 18 18 18 18 18
gluc30 .. 0.06742
-0.23701 -0.27623 -0.27128 -0.33378 .. 0.23495
0.8041 0.3597 0.2832 0.2922 0.1904 0.3640
16 17 17 17 17 17
gluc60 -0.15626 -0.20845 -0.19949 -0.10043 -0.17453 -0.19101
0.5633 0.4220 0.4427 0.7013 0.5029 0.4627
16 17 17 17 17 17
gluc120 -0.32216 -0.07037 -0.02396 0.07003 0.03575 -0.06131
0.2237 0.7884 0.9273 0.7894 0.8916 0.8152
16 17 17 17 17 17
insO 0.02443 0.59290 0.89242 0.37527 0.70791 0.85807
0.9284 0.0155 <.0001 O. 1521 0.0022 <.0001
16 16 16 16 16 16
ins30 0.46298 0.33728 0.20519 0.34743 0.35572 0.16158
0.0709 0.2014 0.4459 0.1873 0.1763 0.5499
16 16 16 16 16 16
ins60 0.62699 0.39444 0.22858 0.00890 0.12839 0.22853
0.0093 0.1306 0.3945 0.9739 0.6356 0.3946
16 16 16 16 16 16
ins120 1.00000 0.40102 0.24575 0.15581 0.24071 0.23455
0.1237 0.3589 0.5645 0.3692 0.3819
16 16 16 16 16 16
bmcg 0.40102 1.00000 0.50632 0.82484 0.92143 0.3505'7
0.1237 0.0270 <.0001 <.0001 0.1411
16 19 19 19 19 19
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Pearson Correlation Coefficients
Prob > Irl under HO: Rho=O
Number of Observations
in5120 bmcg fatg leang totg pctfat
fatg 0.24575 0.50632 1.00000 0.13189 0.59524 0.97929
0.3589 0.0270 0.5904 0.0072 <.0001
16 19 19 19 19 19
leang 0.15581 0.82484 0.13189 1.00000 0.87490 -0.06150
0.5645 <.0001 0.5904 <.0001 0.8025
16 19 19 19 19 19
totg 0.24071 0.92143 0.59524 0.87490 1 .00000 0.42852
0.3692 <.0001 0.0072 <.0001 0.0672
16 19 19 19 19 19
pctfat 0.23455 0.35057 0.97929 ·0.06150 0.42852 1.00000
0.3819 0.1411 <.0001 0.8025 0.0672
16 19 19 19 19 19
131
VITA 2
Jackie L. Brown
Candidate for the Degree of
Master of Science
Thesis: EFFECT OF HIGH-FAT DIET ON BODY COMPOSITION AND HORMONE
RESPONSES TO GLUCOSE TOLERANCE TESTS IN GROWING RATS
Major Field: Nutritional Sciences
Biographical:
Education: Graduated from Muncie Southside High School, Muncie, Indiana,
in June 1988; received Bachelor of Science degree in Nutrition and Food
Management with an option in dietetics, Oregon State University,
Corvallis, Oregon in June 2000.
Completed the requirements for the Master of Science degree with a major
in Nutritional Sciences at Oklahoma State University in August, 2002.
Experience: Volunteered as a nutrition educator in a residential drug and
alcohol treatment center; volunteered as an assistant to a school district
administrative dietitian; employed by Oregon State University Nutrition
and Food Management Department as a food science web page editor;
employed by Oklahoma State University Department ofNutritional
Sciences as a graduate research and teaching assistant.
Professional Memberships: American Dietetic Association, Oklahoma Dietetic
Association, Oregon Dietetic Association.
